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ABBREVIATIONS 
 
AC:  abdominal circumference 
AV:  anterior ventricle 
BPD:  biparietal diameter   
CM:  cisterna magna 
CRL:  crown-rump length 
CTG:  cardiotocography 
DV: ductus venosus 
FGLS: Fetal Growth Longitudinal Study 
FGR:  fetal growth restriction 
FL:  femur length 
HC:  head circumference 
k:  kappa coefficient 
OFD:  occipito-frontal diameter 
QC:  quality control 
SF:  sylvian fissure 
SGA:  small for gestational age 
TC:  transcerebellar 
TCD:  transcerebellar diameter  
TT:  transthalamic 
TV:  transventricular 
POF:  parieto-occipital fissure 
PV:  posterior ventricle 
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INTRODUCTION 
 
 
Fetal brain growth and development is routinely studied using prenatal 
ultrasound. Since the introduction of ultrasound in antenatal care several 
reports confirmed the safety of this health care technology and the benefit 
in improving maternal and perinatal outcome and long term 
neurodevelopmental outcome. Currently ultrasound is recommended 
worldwide as the screening and diagnostic technique of choice in 
pregnancy by international guidelines.1-5 Ultrasound is used mainly in 
antenatal care to diagnose fetal abnormalities.6-14 Fetal anomalies of the 
central nervous system are a major component of fetal abnormalities 
detected antenatally. It is estimated that the incidence from long term 
studies can be as high as 1 in 100 births.2  
Ultrasound can also be used in several diseases and for numerous 
screening purposes15-26 including the assessment of fetal growth as part of 
antenatal care.27 Fetal growth restriction (FGR) along with preterm delivery 
is a major cause of stillbirth, perinatal mortality and abnormal 
neurodevelopment.28 In several studies FGR babies born both preterm 
and at term showed having an increased risk of behavioural problems, 
cognitive deficiency, attentional problems and aggressive behaviour at 
school age.29, 30 
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The prevention and treatment of FGR has the potential of reducing the 
incidence of abnormal neurodevelopmental outcome. This has been 
particularly been demonstrated in the management of severe preterm 
FGR (Appendix 1).31, 32 Controversies still exist on the management of 
FGR at term. This is due to the difficulty in the screening for FGR at term 
as most of fetuses might not be small for gestational age (SGA), and to 
the lack of effective treatments.33 Challenges in clinical care include the 
prevention, screening, diagnosis and treatment of FGR to prevent 
perinatal morbidity and impaired long term neurological outcome.  
The morphology of the brain in FGR fetuses has not been demonstrated to 
have abnormal findings compared with normally grown fetuses.34 
However, in order to study the brain growth and development normally 
grown fetuses without congenital abnormality have to be selected. One the 
aims of the main study reported in this thesis was to create standards for 
fetal structures brain size charts based on serial ultrasound 
measurements. 
The INTERGROWTH-21st is large multicentre, multiethnic, population-
based project, conducted between 2008 and 2013 in eight countries. The 
Fetal Growth Longitudinal Study (FGLS) involves women whose fetuses 
had both two-dimensional and three-dimensional serial scans every 5 
weeks from 14+0 to 41+6 weeks.35 Women participating in this study have 
low-risk pregnancies that fulfil well defined and strict inclusion criteria at 
recruitment.27 
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This study uses a ‘prescriptive’ other than a ‘descriptive’ design to study 
the fetal growth, i.e. only children from populations with minimal 
environmental constraints on growth were included. Previous studies on 
fetal growth are associated with high risk of bias in the methodology used 
(Appendix 2). As a results of such approach the pregnancy outcome of the 
FGLS had a low incidence of common obstetric complications (preterm 
rate: 5%, birth weight at term less than 2.5 kg: 3%, preeclampsia: 1%). As 
in many diseases in obstetrics, risk factors are similar and therefore a 
population at low risk of growth problems is also at low risk of other 
complications. The above findings confirmed the true low risk of the 
population recruited and the fact that this cohort represents the ideal 
candidate sample to construct fetal brain structures international 
standards.  
Ultrasound technology requires the input of several software analysis to 
increase the diagnostic performance and the clinical use. A second line of 
research associated with this theme is reported in this manuscript 
(Appendix 3, 4, 5).  
One of the source of high variability between different charts reporting of 
fetal growth is the absence of a comprehensive quality control strategy in 
fetal ultrasound.36-38 The above has been a novel component of the FGLS 
study39-42 and its result is reported in this manuscript along with other 
studies involving strategies to implement quality control in fetal ultrasound 
(Appendix 6, 7, 8). 
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A systematic review of the literature has been performed to identify all the 
studies aimed to create brain structures charts. Only studies reporting on 
six specific fetal brain structures charts were reported. 
There is substantial heterogeneity in the methodology used in previous 
studies aimed to create brain structures charts.43-52 There is high risk of 
bias in several domains including the selection of the population, the 
ultrasound protocol and the analysis of the data. Less than 10% of the 
identified studies reported on maternal and fetal inclusion criteria, 
pregnancy outcome, ultrasound quality control and statistical description. 
Most importantly, no studies reported on long term infant outcome, most 
probably due to the retrospective descriptive design of the study. The data 
collection was in fact non-specific for the purpose of the study. Not 
surprisingly, these are common finding in creating fetal biometry charts as 
found in previous systematic reviews.36, 38 
In the last chapter of this manuscript it is reported the study focused on the 
main objective which is to create international standards for six fetal brain 
structures by antenatal ultrasound and provide further understanding into 
the fetal brain development process (Appendix 9). The study was 
conducted in women taking part in the INTERGROWTH-21st Project 
whose babies have a low risk of abnormal neurological outcome.  
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FETAL GROWTH AND FETAL BRAIN DEVELOPMENT 
 
 
FGR is defined as the failure of a fetus to reach his own growth potential. 
Most FGR fetuses are SGA but not all of them are growth restricted.  
FGR affects between 5 and 10% of fetuses. More than 20 millions 
newborns have a birth weight less than 2,5 kg worldwide, two third of them 
have evidence of FGR at birth. These figures are increased in low income 
countries and they contribute to 95% of low birth weights infants around 
the world. Most of those babies are born at term (> 37 weeks of gestation) 
and therefore the vast majority of FGR cannot be attributable to preterm 
delivery.53  
Chronic placental insufficiency is a common cause of FGR. Placental 
insufficiency or utero-placental dysfunction results in insufficient blood flow 
to the placenta during pregnancy and inadequate supply of nutrients and 
oxygen to support normal growth of the fetus. Thus, the fetus develops in 
a chronic hypoxic environment. Placental insufficiency can result in 
changes in fetal metabolism, hormones, haematology, immunology and 
cardiovascular function.54 
One of the major challenge of modern obstetric practice is to screen, 
diagnose and furnish tools to treat FGR, mainly using ultrasound. The 
usefulness and limitations of such screening methods have been 
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evaluated in randomised controlled trials over the last two decades.55 In 
some pregnancies and newborns, especially those that are preterm, there 
is a need to monitor growth more closely to decide if clinical interventions 
are required. So far non optimal timing for delivery and no treatment has 
been reported in the management of SGA and FGR at term to improve the 
neurodevelopmental outcome.56  
It is unclear why newborns who suffered from FGR have an increased risk 
of neurological delay, independently from the gestation at delivery.57 Most 
studies report an increased incidence of hypoxia leading to hypoxemia. 
Other causes such as neuroinflammation54 and abnormal metabolites 
production can have an impact on the developing brain.58 
Independently from the above factors it is largely recognised that there is a 
‘fetal programming’ of the adult life. A fetus whose mother is exposed to 
factors that led to adverse intrauterine milieu is more susceptible to adult 
diseases.59 One of the mechanism through which the fetus compensate 
with the chronic hypoxia is the phenomenon of redistribution of the blood 
flow. This consists into the increase in the blood flow to the brain, the 
upper part of the body and the most vital organs (surrenal gland, brain and 
heart). This mechanism has been demonstrated to be associated with 
abnormal neonatal and long term neurological outcome. In two systematic 
reviews of the literature, SGA and FGR with abnormal cerebral 
redistribution is associated with increased risk of abnormal 
neurodevelopment in the cognitive, language, motor, behaviour, vision and 
hearing domain.28, 57 The above evidence reinforces the findings of higher 
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risk of abnormal development with increasing severity of the growth 
restriction.  
From the ultrasound point of view the above findings are associated with 
increased resistance in the umbilical artery blood flow, a decrease in the 
resistance in the middle cerebral artery, and increased resistance in the 
ductus venosus (DV) (the latter mainly in severe preterm FGR). All the 
above fetal vessels can be studies through Doppler assessment at 
antenatal ultrasound. Those blood flow alterations reflect a change in the 
cardiovascular function of the fetus. The sympathetic and parasympathetic 
nervous system is also affected by the hypoxic status which can be 
evaluated by fetal cardiac responses to stimuli. The cardiotocography 
(CTG) is a health technology which can register the heart rate fluctuations 
generated by the nervous system and record the fetal wellbeing status. It 
has been largely used as an intrapartum monitoring technique but the use 
of computerised assessment has been reported as an antenatal predictor 
of hypoxia in FGR fetuses, especially preterm.  
Despite no interventional trials are reported on the management at term a 
recent study was published on the management of FGR before 32 weeks 
of gestation. The TRUFFLE study is a prospective, European multicentre, 
unblinded, randomised study, where women with singleton fetuses at 26–
32 weeks of gestation who had very preterm FGR (SGA associated with 
increased resistances in the umbilical artery) were randomly allocated to 
three timing of delivery plans, which differed according to antenatal 
monitoring strategies. They were based on the computerised ultrasound 
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assessment of the fetal heart rate (CTG) and the assessment of Doppler 
velocimetry in the DV. Delivery plans differed according to three antenatal 
monitoring strategies: CTG abnormality, early DV changes or late DV 
changes. The primary outcome was survival without cerebral palsy or 
neurosensory impairment, or a Bayley III developmental score of less than 
85, at 2 years of age. Outcomes assessed were surviving infants with 
known outcomes at 2 years.31, 32 542 eligible women were randomly 
allocated to monitoring groups. The median gestational age at delivery 
was 30.7 weeks and mean birthweight was 1019 grams. The proportion of 
infants surviving without neuroimpairment did not differ between the CTG 
arm (111 [77%] of 144 infants with known outcome), early DV changes 
(119 [84%] of 142), and late DV changes (133 [85%] of 157) groups. 12 
fetuses (2%) died in utero and 27 (6%) neonatal deaths occurred. Of 
survivors, more infants where women were randomly assigned to delivery 
according to late ductus changes (133 [95%] of 144) were free of 
neuroimpairment when compared with those randomly assigned to CTG 
(111 [85%] of 131), but this was accompanied by a non-significant 
increase in perinatal and infant mortality. The conclusion of the study was 
that timing of delivery based on the study protocol using late changes in 
the DV waveform might produce an improvement in developmental 
outcomes at 2 years of age. 
Being this cohort of women high risk, many infants in the TRUFFLE study 
were delivered because of other maternal and fetal indications. It was the 
objective of a secondary study to present a post‐hoc sub‐analysis to 
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investigate the indications for delivery in relation to outcome at 2 years in 
infants delivered before 32 weeks, to come to a further refinement of 
management proposals of severely FGR babies (Appendix 1).60 The study 
findings were that overall only 32% of fetuses born alive were delivered 
according to the specified monitoring parameter for indication for delivery. 
There was an increase rate of intact neurological survival in fetuses 
randomised into the DV arms. Therefore, the optimal timing of delivery can 
be achieved by combined longitudinal monitoring using both computerised 
CTG and DV. 
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Appendix 1: The TRUFFLE study; fetal monitoring 
indications for delivery in 310 IUGR infants with 2 year’s 
outcome delivered before 32 weeks of gestation 
 
This is study has been accepted for publication but the final proof is under 
the review of the TRUFFLE scientific group and it might undergo 
substantial review of the data before the final publication in the journal.  
 
Gerard H.A.Visser (1), C.M Bilardo (2), J.B.Derks (1), E Ferrazzi (3), 
N.Fratelli (4), T. Frusca (5), W. Ganzevoort (6), C.Lees (7), R. Napolitano 
(8), T.Todros (9), H.Wolf (6), K.Hecher (10) on behalf of the TRUFFLE 
group investigators* 
 
1. Department of Perinatology, University Medical Center, Utrecht, 
Netherlands 
2. Department of Obstetrics and Gynaecology, University Medical Center, 
University of Groningen, Netherlands 
3. Department of Woman, Mother and Neonate, Buzzi Children's Hospital, 
University of Milan, Milan, Italy 
4. Maternal‐Fetal Medicine Unit, University of Brescia, Brescia, Italy 
5. Department of Obstetrics and Gynecology, University Hospital, Parma, 
Italy 
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6. Department of Obstetrics and Gynecology, Academic Medical Centre, 
Amsterdam, Netherlands 
7. Department of Surgery and Cancer, Imperial College London, London, 
UK; and Department of Development and Regeneration, KU Leuven, 
Leuven, Belgium  
8. Department of Gynecology and Obstetrics, University Federico II of 
Naples, Naples, Italy 
9. Department of Obstetrics and Gynecology, Sant’ Anna Hospital, Turin, 
Italy 
10. Department of Obstetrics and Fetal Medicine, University Medical 
Center, Hamburg‐Eppendorf, Germany 
 
*TRUFFLE group investigators: N Marlow (11) , B Arabin (12) , C Brezinka 
(13), A Diemert (10), JJ Duvekot (14), P Martinelli (7), E Ostermayer (15), 
AT Papageorghiou (16), D Schlembach (17), KTM Schneider (15), B 
Thilaganathan (16), A Valcamonico (4). 
 
11. Department of Neonatology, UCL Institute for Women's Health, 
London, UK 
12. Center for Mother and Child of the Phillips University, Marburg, 
Germany 
13. Obstetrics and Gynecology, Universitatsklinik fur Gynakologische 
Endokrinologie und Reproduktionsmedizin, Department fur 
Frauenheilkunde, Innsbruck, Austria 
   
 
16 
14. Department of Obstetrics and Gynaecology, Erasmus MC, Rotterdam, 
Netherlands 
15. Division of Perinatal Medicine, Department of Obstetrics and 
Gynecology, Technical University, Munich, Germany 
16. Department of Obstetrics, St George's, University of London, London, 
UK 
17. Department of Obstetrics, Friedrich Schiller University of Jena, Jena, 
Germany 
 
TRUFFLE group collaborators: A Aktas (Marburg), S Borgione (Turin), R 
Chaoui (Berlin), JMJ Cornette (Rotterdam), T Diehl (Hamburg), J van Eyck 
(Zwolle), IC van Haastert (Utrecht), J Kingdom (Toronto), S Lobmaier 
(Munich), E Lopriore (Leiden), H Missfelder Lobos (Cambridge), G Mansi 
(Naples), P Martelli (Brescia), G Maso (Trieste), K Marsal (Lund), U 
Maurer‐Fellbaum (Graz), N Mensing van Charante (Amsterdam), S 
Mulder‐de Tollenaer (Zwolle), M Oberto (Turin), D Oepkes (Leiden), G 
Ogge (Turin), JAM van der Post (Amsterdam), F Prefumo 
(Brescia/London), L Preston (Cambridge), F Raimondi (Naples), H Rattue 
(London), IKM Reiss (Rotterdam), LS Scheepers (Nijmegen/Maastricht), A 
Skabar (Trieste), M Spaanderman (Nijmegen), J Thornton (Nottingham), H 
Valensise (Rome), N Weisglas–Kuperus (Rotterdam), A Zimmermann 
(Munich). 
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“This article has been accepted for publication and undergone full peer 
review but has not been through the copyediting, typesetting, pagination 
and proofreading process, which may lead to differences between this 
version and the Version of Record. Please cite this article as doi: 
10.1002/uog.17361. This article is protected by copyright. All rights 
reserved.” 
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ABSTRACT 
 
Objective: In the TRUFFLE study on outcome of early fetal growth 
restriction women were allocated to three timing of delivery plans 
according to antenatal monitoring strategies based on reduced 
computerized cardiotocographic heart rate short term variation (c‐CTG 
STV) , early Ductus Venosus (DV p95) or late DV (DV noA) changes. 
However, many infants were per protocol delivered because of ‘safety net’ 
criteria, or for maternal indications, or ‘other fetal indications’ or after 32 
weeks of gestation when the protocol was not applied anymore. It was the 
objective of the present post‐hoc sub‐analysis to investigate the 
indications for delivery in relation to outcome at 2 years in infants delivered 
before 32 weeks, to come to a further refinement of management 
proposals. 
 
Methods: We included all 310 cases of the TRUFFLE study with known 
outcome at 2 years corrected age and 7 perinatal and infant deaths, apart 
from 7 cases with an inevitable death. Data were analysed according to 
the randomization allocation and specified for the intervention indication. 
 
Results: Overall only 32% of fetuses born alive were delivered according 
to the specified monitoring parameter for indication for delivery. 38% were 
delivered because of safety net criteria, 15% because of other fetal 
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reasons and 15% because of maternal reasons. In the c‐CTG arm 51% of 
infants were delivered because of reduced STV. In the DV p95 arm 34% 
were delivered because of an abnormal DV and in the DV no A wave arm 
only 10% of cases were delivered accordingly. The majority of fetuses in 
the DV arms delivered for safety net criteria were delivered because of 
spontaneous decelerations. Two year’s intact survival was highest in the 
combined DV arms as compared to the c-CTG arm (p=0.05 when life born, 
p= 0.21 including fetal death), with no difference between the DV arms. 
Poorer outcome in the c‐CTG arm was restricted to fetuses delivered 
because of decelerations in the safety net subgroup. Infants delivered 
because of maternal reasons had the highest birth weight and a 
non‐significant higher intact survival. 
 
Conclusions: In this sub‐analysis of fetuses delivered before 32 weeks the 
majority of infants were delivered for other reasons than according to the 
allocated CTG or DV monitoring strategy. Since in the DV arms CTG 
criteria were used as safety net criteria, but in the c‐CTG arms no DV 
safety net criteria were applied, we speculate that the slightly poorer 
outcome in the CTG arm might be explained by absence of DV data. 
Optimal timing of delivery of the early IUGR fetus may therefore best be 
achieved by monitoring them longitudinally with DV and CTG monitoring. 
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INTRODUCTION 
 
The 2 year outcome data of the TRUFFLE study (‘Trial of Umbilical and 
Fetal Flow in Europe’) on outcome of early intrauterine growth restricted 
(IUGR) fetuses has shown that overall outcome of these fetuses was more 
favourable than published in the past (1). Timing of delivery was 
randomized and based on reduced computerized cardiotocograph heart 
rate short term variation (c‐CTG STV), and early or late pulsatility changes 
in the Ductus Venosus (DV), with safety net criteria in all three intervention 
strategies. 
Impaired outcome (mortality and severe morbidity) did not differ 
significantly between cases delivered in the three arms of the trial, but 
data on intact two year’s neurological outcome showed that a conservative 
approach to the timing of delivery by waiting for late DV changes, was 
associated a better outcome in the survivors as compared to the c‐CTG 
arm. Data were analysed according to intention to treat. However, a 
considerable proportion of infants was delivered per protocol because of 
co‐called ‘safety net’ criteria (i.e. severely reduced c‐CTG STV, 
occurrence of spontaneous unprovoked heart rate decelerations, or ‐after 
30 weeks‐ because of reversed end‐diastolic flow velocities (ReDV) in the 
umbilical artery, without abnormalities in DV flow velocity waveform 
patterns). 
Since cardiotocography is the standard of care in monitoring of IUGR 
fetuses at risk of impaired intra‐uterine condition, c‐CTG STV safety net 
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criteria were established for patients randomized to the DV groups only, 
while DV was not evaluated in patients randomized to CTG monitoring. 
Moreover, in all 3 arms of the trial many infants were delivered because of 
maternal indications or ‘other fetal indications’ or after 32 weeks of 
gestation, when delivery occurred according to local protocols and not 
according to the intention to treat arms of the protocol. Therefore, there is 
the need for a post‐hoc sub‐analysis of the TRUFFLE data, especially for 
infants delivered before 32 weeks to investigate outcome at 2 years in 
relation to the indications for delivery, to come to a further refinement of 
management proposals. 
 
 
METHODS 
 
In the multicenter, unblinded, randomised TRUFFLE study we included 
women with singleton fetuses at 26–32 weeks of gestation who had very 
preterm fetal growth restriction (ie low abdominal circumference [<10th 
percentile] and a high umbilical artery Doppler pulsatility index [>95th 
percentile]). We randomly allocated women 1:1:1, with randomly sized 
blocks and stratified by participating center and gestational age (<29 
weeks vs ≥29 weeks), to three timing of delivery plans, which differed 
according to antenatal monitoring strategies: reduced c‐CTG STV (STV 
<3.5 ms at <29 weeks of gestation or STV <4 ms at ≥29 weeks of 
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gestation), early DV changes (pulsatility index >95th percentile; DV p95), 
or late DV changes (zero or reversed A wave; DV no A). The safety net 
c‐CTG STV criteria as used in the two DV groups were set considerably 
lower than in the CTG STV arm, namely ≥26 ‐ <29 weeks if STV < 2.6 and 
≥30 ‐ <32 weeks if STV< 3. Joint safety‐net criteria for all three 
randomisation arms included the occurrence of spontaneous decelerations 
and, after 30 weeks, reversed end‐diastolic flow velocities (REDV) in the 
umbilical artery. The primary outcome was survival without cerebral palsy 
or neurosensory impairment, or a Bayley III developmental score of more 
than 85, at 2 years of age. This study was registered with ISRCTN, 
number 56204499. Between January 2005 and October 2010 503 women 
were included. Results on direct neonatal and 2 year’s outcome have 
been published before (1,2). 
In this post‐hoc sub‐analysis we included all 310 live born cases of the 
TRUFFLE study with known outcome at 2 years corrected age, that were 
delivered before 32 weeks of gestation and 7 fetal deaths. Cases in which 
it was refrained from intervention before birth because of suspected poor 
prognosis of the infant (n=5) and 2 cases born with a lethal congenital 
malformation were not included (2). There were 25 neonatal deaths that 
were included in the analyses. Most of the analyses were made on the 
310 life born cases. However, for comparison with the data from the 
original TRUFFLE study and where appropriate, data are also shown for 2 
year’s survivors only. Data were analysed according to the randomization 
allocation specified for the intervention indication. Data were analysed by 
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anova or chi‐square test as appropriate, using IBM SPSS version 22 (New 
York, USA). 
 
 
RESULTS 
 
We included 310 infants born alive before 32 weeks of gestation and 7 
fetal deaths. The number of infants born alive according to randomization 
arm and intervention indication is shown in Table 1. Overall two‐third of 
the infants were delivered according to the specified criteria of the 
randomization strategies. Slightly more than half of these were delivered 
because of safety net criteria. The remaining one‐third of the study 
population was delivered because of other off-protocol fetal indications or 
for maternal indications. In the c‐CTG STV arm 54 of 104 infants (51%) 
were delivered because of reduced STV. In 19 of these cases also 
decelerations were present. In the DV arms delivery because of a 
DV>95th centile was the reason for delivery in 34% of cases allocated to 
that arm and in the DV no A wave arm only 10% of cases were delivered 
for absent or reversed A‐wave. In the latter group over 50% of cases were 
delivered because of safety net criteria and almost 40% because of other 
fetal or maternal indications. The 7 fetal deaths occurred in the latter two 
groups (3 in the DV P95 and 4 in the DV no A wave group). 
The Supplementary Table shows gestational age and weight at delivery 
according to randomisation and indication for delivery. There were no 
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significant differences between the subgroups, although birth weight was 
higher in infants delivered for maternal indications (anova, corrected for 
multiple testing, p=0.02), while gestational age was similar, as compared 
to the other indication groups. 
Outcome at 2 years is shown in Table 2. Overall 83% of live born infants 
were alive without neurological impairment at 2 years of age. This 
percentage was 86 for infants delivered in both DV arms and 77 for those 
delivered in the c‐CTG arm (p=0.049 for live born infants if comparing 
CTG‐STV to both DV groups combined). 
There were 7 fetal deaths, all in the DV arms. When these deaths were 
included, intact outcome in the DV arms decreased to 83% (p=0.21 when 
compared to the CTG arm). Overall the most favourable outcome (92%) 
occurred in infants delivered because of maternal reasons and this held 
for all 3 randomization arms (p=0.09 for maternal versus all other 
indications, excluding fetal death). The lowest incidence of intact outcome 
(15 of 26; 58%) occurred in the infants in the CTG arm delivered because 
of safety net criteria. Outcome in this group was significantly poorer than 
that in the DV arms in which delivery took place on the basis of safety net 
criteria (p=0.001) . In fact, the poorer outcome in the CTG arm was only 
due to a poorer outcome in the safety net subgroup. There was no 
difference in 2 year’s outcome between infants that were delivered based 
on the c‐CTG STV criteria (favourable outcome in 44 of 54; 82%), as 
compared to those delivered based on DV criteria (combined group n=45, 
favourable outcome in 36, 80%). Results were similar when the 25 
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neonatal deaths were excluded. In the c‐CTG arm 81 of 95 survivors 
(85%) had a normal neurological outcome, as compared to 176 of 190 
(93%) in the combined DV groups (Table 2; p=0.049). The lowest 
incidence of intact survival occurred in the infants in the c‐CTG group 
delivered because of safety net (15 of 22 (68%), versus 80 of 85 in the 
combined DV groups (94%)), with no differences in intact survival in case 
delivery was based on the specified CTG abnormality in the c‐CTG arm 
(44 of 50; 88%) or DV abnormality in the combined DV arms (36 of 41; 
88%). 
Table 3 shows a sub‐division of the safety net criteria according to the 
randomization arms. Low STV was only a safety net criterion in the DV 
groups. The other criteria held for all 3 groups (joined criteria). 67% of 
infants in the safety net group were delivered because of decelerations, 
12% because of a low STV, another 15 % because of a combination of 
both and only 6% because of ReD velocities in the umbilical artery at a 
gestational age >30 weeks. In the combined DV arms very low STV alone 
was an indication for delivery in only 14 out of 92 cases (15%) and a very 
low STV combined with decelerations in another 18 cases (20%); 
decelerations, with or without low STV were by far the most important 
determinant for delivery in the DV arms (79%). When delivery was 
indicated by decelerations then adverse 2‐year infant outcome was 
significantly more frequent in the CTG‐STV arm than in the DV‐groups 
(p=0.003). For the other safety net criteria outcome was not significantly 
different from the overall 2‐year infant outcome. (Table 3), although all 7 
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cases delivered because of ReDV in the umbilical artery after 30 weeks 
did well. 
In 19 of the 54 cases in the CTG arm delivered because of STV criteria 
(Table 1) also decelerations were present. In a further 24 only 
decelerations were present (Table 4). In other words, in the CTG arm 
slightly more fetuses were delivered because of reduced STV than 
because of decelerations. When leaving out infants delivered because of 
maternal reasons, ReD flow umbilical artery or off‐protocol (i.e.: infants in 
which there were no recorded CTG or DV abnormalities), altogether 210 
infants were delivered because of CTG (STV with decelerations) or DV 
abnormalities. 165 of these infants were delivered because of CTG and 45 
because of DV. Of the infants delivered because of an abnormal DV, 80 % 
were normal at follow‐up (36 of 45) and that held for 83% delivered 
because of CTG abnormalities. (132 of 165). The only fetuses monitored 
with both CTG and DV, were those in the two DV arms. Even in these 
arms twice as many infants (n=87) were delivered because of CTG safety 
net STV and/or decelerations than because of DV changes (n=45). 
Slightly more infants delivered because of CTG were normal at follow‐up 
(75 of 87, 86%; see Table 3), as compared to 80% delivered because of 
DV (36 of 45; see Table 3). So these data indicate that overall outcome of 
infants delivered because of CTG changes was at least similar to those 
delivered because of DV abnormalities. Only in the subgroup, monitored 
with only c‐CTG without DV, outcome was poorer. 
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DISCUSSION 
 
We have performed a post‐hoc sub‐analysis of outcome of infants from the 
TRUFFLE trial who were delivered before 32 weeks of gestation. By doing 
so we excluded infants born ≥ 32 weeks, who were likely to be at lower 
risk for impaired outcome and were delivered according to local 
management criteria and not according to the initial randomization arms 
(1). This analysis was done to obtain more insight in 2 year’s outcome in 
relation to the actual indications for delivery. A disadvantage of the smaller 
size of this study was the fact that it was not powered for the questions 
raised. Conclusions have, therefore, to be drawn with caution. 
We found that 2 year’s outcome was better in the DV arms as compared 
to the CTG arm and this is in line with that of the total study population (1). 
In the original TRUFFLE study primary outcome, i.e.: survival without CP 
or neurosensory impairment, was not significantly different between the 
randomization arms, but neurological outcome in survivors was 
significantly better in the DV no A wave arm as compared to that in the 
CTG arm, with a trend towards better outcome in the DV>95th centile arm. 
When specified for the actual indication for delivery (specified CTG or DV 
abnormality, safety net, other fetal indications, maternal indications) we 
found no differences between groups in two year’s outcome, although 
those delivered for maternal indication had a non‐significantly better 
outcome. The latter may be related to a significantly higher birth weight at 
the same age at delivery. In the DV no A group more fetuses were 
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delivered because of other fetal indications or maternal indications, than in 
the other arms of the trial. The reason is unclear also since ‘’other fetal 
indications’’ was not specified enough by the participating centres, apart 
from cases with partial placental abruption. Waiting for late DV changes 
may have increased the chance for CTG and other fetal indications to 
arise. 
The better outcome in the DV groups appears initially somewhat difficult to 
explain given the fact that only 35 and 10% of infants in the DV p95 and 
DVnoA arm, respectively, were actually delivered because of the allocated 
DV abnormalities, whereas 52 and 73%, respectively, were delivered 
because of safety net or other fetal indications. The safety net criteria 
largely relate to the occurrence of fetal heart rate decelerations or a very 
reduced STV, i.e. CTG criteria. Altogether more infants in the DV arms 
were delivered on the basis of CTG safety net criteria than on the basis of 
an abnormal ductus flow velocity pattern. This implies that in the majority 
of cases CTG abnormalities (STV and/or decelerations) preceded DV 
changes. From longitudinal studies it is known that c‐ CTG STV and DV 
changes occur more or less at the same time in early IUGR fetuses (3,4). 
In other words in half of the cases changes in c‐CTG STV precede DV 
changes, but also the opposite holds true. The differences in outcome 
may, therefore, be related to the study design in which in the DV groups 
CTG safety net criteria were included, whereas in the CTG arm no DV 
measurements were obtained. From earlier studies we know that survival 
in early IUGR is higher if either CTG or DV anomalies had been present as 
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compared to cases in which both had been abnormal (3,4,5). The poorer 
outcome in the c‐CTG group may therefore, be due to the fact that in this 
arm in a substantial number of cases both CTG and DV abnormalities had 
been present. Outcome of fetuses in the CTG arm delivered on the basis 
of c‐CTG STV was identical to that of those delivered in the combined DV 
arms on the basis of DV abnormalities. It therefore seems essential to 
include c‐CTG when determining the timing of delivery. The significantly 
poorer outcome in the CTG safety net group delivered because of 
decelerations, as compared to the DV arms delivered because of this 
criterion, may well indicate, that absence of knowledge on DV in this 
subgroup has delayed delivery and has been causal to the poorer 
outcome. In this context it has to be realised the TRUFFLE study was a 
comparison of CTG monitoring only, with combined DV and CTG 
monitoring. Our data stress the importance of monitoring early IUGR 
fetuses with both CTG and DV. In clinical practice this implies that when 
monitoring early IUGR fetuses with both techniques, the majority will be 
delivered because of CTG abnormalities before DV changes occur. DV 
may therefore be considered the ‘’safety net’’ for CTG monitoring. Such a 
safety net seems useful, also since the data from the original TRUFFLE 
trial and the ones from the present sub‐analysis have shown that 
monitoring with CTG alone ( without a DV safety net), resulted in a poorer 
outcome, than when combining both assessment techniques. 
STV threshold values for normality may not be clear at this moment. We 
have defined normal STV as a STV > 3.5 ms in between 26‐28 weeks of 
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gestation and > 4 in between 29 till 32 weeks (1). These threshold values 
were set taken into account the increase in STV with increasing 
gestational age (6,7), the absence of fetal acidaemia in case of a STV>4 
ms (8) and presence of acidaemia or hypoxaemia in the majority of cases 
when STV was in between 3.5‐4 ms (9). The 2.5th centile of STV in 
normal populations has been found to be around 4‐5 ms in the early third 
trimester in recordings of variable length (10) or around 4.4‐5.4 in CTG 
recordings of one hour duration (6,7). Therefore, we have used a lower 
STV threshold values in the present study. However, it is known that fetal 
heart rate decelerations occur on average at the same time as heart rate 
variation falls below the normal range (11). Since in the present study 
slightly more fetuses in the c‐CTG arm were delivered on the basis of 
reduced STV than because of decelerations, it seems unlikely that the 
STV threshold values in the CTG arm were set too low. 
The fact that most fetuses in the DV arms that were delivered on safety 
net indications were delivered on the basis of decelerations and not on the 
applied very low STV cut‐off values, suggests that the latter values might 
have been set too low. Therefore, it may be that the same criteria used in 
the c‐CTG arm should be used. The more so since outcome in the c‐CTG 
arm of fetuses delivered according to the specified monitoring parameter, 
was identical to that of cases delivered in the DV arms because on an 
abnormal DV. However, the optimal STV cut‐off values might be subject to 
further analysis. The more so, since we had no information on DV in the 
c‐CTG arm and it may therefore be that cases with a reduced STV 
   
 
31 
according to the c‐CTG arm might have been identified by DV 
abnormalities. It should also be noted that the TRUFFLE STV threshold 
values were based on one hour CTG recordings. Shorter recordings may 
give less accurate results (1,2,6). Moreover, possible effects of medication 
like betamethasone and MgSO4 should be taken into account, since both 
drugs may reduce STV without affecting the occurrence of decelerations 
(12‐16).  
Taken into account the restriction that the present post‐hoc sub‐analysis 
was not powered for the questions raised in this paper, the present data 
suggest some refinement in the management protocol of early IUGR 
fetuses delivered before 32 weeks of gestation:  
1‐ the optimal timing of delivery may best be achieved by combined 
longitudinal monitoring using both c‐CTG and DV. Given that low STV 
(<2.6 before 29 weeks and <3 between 30 and 32 weeks) do not appear 
to be associated with an increase in adverse outcome and it may be safe 
to wait for such abnormalities to occur as long as DV remains normal. 
2‐ the favourable outcome in the small group of fetuses delivered 
because of reversed end‐diastolic velocities in the umbilical artery after 30 
weeks of gestation, supports the use of this criterion after this gestational 
age. 
The data from this sub‐analysis based on the actual indications for 
delivery in infants delivered before 32 weeks of gestation, support those of 
the whole TRUFFLE study, whereby it has to be realised that almost 2/3rd 
of cases will be delivered per protocol because of other indications than 
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CTG in the c‐CTG arm, or abnormal DV in the DV arms. This held 
especially for fetuses allocated to the DV arms. Overall, outcome of IUGR 
fetuses delivered before 32 weeks, appears to be better than historical 
data have shown and this is likely to be due to the close multi‐modality 
(Doppler and c‐CTG) monitoring. 
   
 
33 
 
Table 1: Number of infants born alive (n=310) before 32 weeks of gestation according to 
randomisation arm (intention to treat) and intervention indication. ReDV: Reversed 
end‐diatolic velocities umbilical artery. 
 
c-CTG 
STV 
DV p95 DV no A All 
Indication for delivery:     
According to randomization arm:     
- Specified CTG or DV 
abnormality 
54 34 11 99 (32%) 
- Safety net, total 
26 37 55 118 (38%) 
- DV STV safety net 
- criteria* 
 11 21  
- Joint safety net criteria: 
    
Spontaneous decel 24 22 33  
ReDV >30 weeks 2 4 1  
Other fetal indications 9 15 22 46 (15%) 
Maternal 16 13 18 47 (15%) 
Total 105 99 106 310 
 
*STV<2.6 before 29 weeks and <3 after 29 weeks 
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Table 2: Number of infants with normal neurological follow-up and total number with 
known outcome, specified for the indication of delivery and randomization allocation. 
Selected were only infants delivered before 32 weeks, fetal death due to inevitable poor 
prognosis and neonatal death due to a lethal anomaly were excluded. In ’total including 
fetal death’ the 7 antepartum deaths were included and in ‘total, survivors only’ outcome 
in the 285 survivors is shown. 
Indication for delivery  c-CTG STV DV p95 DV no A All 
According to randomization arm:     
- Specified CTG or DV 
abnormality 
44/54 (82%) 26/34 (77%) 10/11 (91%) 80/99 (81%) 
- Safety-net 
15/26 (58%) 34/37 (92%) 46/55 (84%) 
95/118 
(81%) 
Other fetal indications* 
7/9  
(78%) 
14/15  
(93%) 
18/22  
(82%) 
39/46            
(85%) 
Maternal 15/16 (94%) 11/13 (85%) 17/18 (94%) 43/47 (92%) 
Total, liveborn infants with known outcome 81/105 (77%) 
85/99  
(86%) 
91/106 (86%) 
257/310 
(83%) 
Total included fetal death 
81/105 
(77%) 
85/102 
(83%) 
91/110 
(83%) 
257/317 
(81%) 
Total, survivors only 
 
81/95 
(85%) 
85/93 
(91%) 
91/97 
(94%) 
257/285 
(90%) 
 
*including 8 cases of partial abruption (2, 2 and 4, respectively; all these infants did well) 
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Table 3: Sub-division of safety net criteria for randomisation allocation for infants with 
normal or abnormal neurological follow-up at 2 year’s of age and total number. ReDV= 
reversed end-diastolic velocities umbilical artery 
Safety-net indications for delivery c-CTG  STV DV p95 DV no A Total 
Low STV* only - 2 12 14 
Normal outcome - 1 9 71% 
Abnormal outcome - 1 3  
Decelerations only 24 22 33 79 
Normal outcome 13 20 27 76% 
Abnormal outcome 11 2 6  
Low STV* with decelerations  9 9 18 
Normal outcome  9 9 100% 
Abnormal outcome  0 0  
ReDV > 30 weeks 2/2 4/4 1/1 7 
Normal outcome 2 4 1 100% 
Abnormal outcome 0 0 0  
Total 26 37 55 118 
Normal outcome 15 (58%) 34 (92%) 46 (84%) (81%) 
Abnormal outcome 11 (42%) 3 (8%) 9 (16%)  
 
* DV group only 
   
 
36 
Supplementary Table: Median gestational age and weight of infants born alive (n=310) 
before 32 weeks of gestation according to randomisation arm and intervention indication 
(fetal death excluded). 
 Indication for 
delivery 
N c-CTG DV p95 DVnoA All 
N  105 99 106 310 
  GA BW GA BW GA BW GA BW 
Specified CTG 
or DV 
abnormality 
99 
29.5 
(28.6 to 
30.9) 
901 
(198) 
29.4 
(28.1 to 
30.6) 
832 
(208) 
29.9 
(28.6 to 
30.9) 
851 
(275) 
29.6 
(28.6 to 
30.9) 
872 
(211) 
Safety net 
118 
29.9 
(28.4 to 
30.6) 
832 
(175) 
30.0 
(28.6 to 
31.2) 
881 
(221) 
29.9 
(28.7 to 
30.7) 
885 
(221) 
29.9 
(28.6 to 
30.9) 
872 
(211) 
Other fetal 
indications 46 
30.0 
(28.9 to 
30.7) 
851 
(180) 
30.3 
(29.0 to 
31.1) 
932 
(183) 
30.4 
(29.2 to 
31.0) 
875 
(139) 
30.3 
(29.0 to 
31.0) 
889 
(162) 
Maternal 
47 
29.8 
(27.9 to 
31.4) 
956 
(251) 
30.0 
(29.3 to 
30.9) 
1019 
(258) 
29.8 
(28.0 to 
30.7) 
901 
(198) 
29.9 
(28.4 to 
31.0) 
952 
(234) 
All 
310 
29.7 
(28.5 to 
30.9) 
888 
(202) 
29.9 
(28.7 to 
31.0) 
890 
(222) 
29.9 
(28.7  to 
30.8)  
882 
(207) 
29.9 
(28.7 to 
30.9) 
887 
(209) 
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PRESCRIPTIVE GROWTH CHARTS METHODOLOGY 
 
 
Growth monitoring is essential in antenatal and newborn care worldwide, 
as it is for infants and children and it requires comprehensive 
anthropometric standards.61 
These tools have been available to evaluate term infants’ postnatal 
growth, but not fetal growth, newborn size, or the postnatal growth of 
preterm newborn infants. ‘Descriptive’ reference charts, rather than 
‘prescriptive’ standards, are used in obstetric and neonatal practice. 
Standards are preferable because they describe aspirational, biologic 
norms that are achieved by healthy populations (‘how a population should 
grow’). References, on the other hand, describe the distribution of 
variables that are observed in unselected samples at a given time and 
place (‘how a population has grown’).62 Furthermore, the higher is the risk 
of developing perinatal complications the higher is the risk that a reference 
derived would be influenced by clinical management causing the 
impossibility of establishing how a baby should have grown. 
Reference charts to assess fetal growth, as for example, the popular 
Hadlock charts of estimated fetal weight, are based on selected 
populations not reflecting current standards of growth (109 fetuses from 
Texas in the 1980).63 One of the issues with the use of reference charts is 
the large number and limited methodologic quality of the charts that are 
available to obstetricians and neonatologists. In a series of systematic 
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reviews, several domains at high risk of bias where found in describing the 
fetal and neonatal growth.36, 38, 64, 65 In a review aimed to evaluate the 
methodology used in studies to create fetal growth measurements 
substantial heterogeneity was found. 83 published fetal size charts for 
monitoring growth by ultrasound scanning were selected and there were 
high risk of bias in pregnancy dating, ultrasound methodology, sample 
selection, statistical analysis. Even selecting the best quality studies there 
was such a high variability in centiles reported that the 10th centile for 
abdominal circumference in one study at a specific gestation was similar 
to the 50th centile at the same gestation in another study. 
Similar findings were found in studies aimed to create pregnancy dating 
charts by crown-rump length (CRL). In the study presented in this 
manuscript a systematic review was performed, out of 29 studies selected, 
4 studies were reported having the lowest percentage of methodological 
bias (Appendix 2). Despite the high quality of the four studies selected, 
using one dating equation rather than another would lead to variability on 
average between 0 and 4 days in estimating the date of delivery. 
Because of the above reason the INTERGROWTH-21st Project was 
conducted in order to complement the World Health Organization (WHO) 
Child Growth Standards study,66 that was derived from healthy newborn 
infants from populations with few growth-restricting factors whose mothers 
followed breastfeeding recommendations. This study revealed no 
significant differences in growth patterns according with the country of 
origin.  
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The INTERGROWTH-21st is a multicentre, multiethnic, population-based 
project done between 2009 and 2014, in eight sites in eight countries: 
Brazil, Italy, Oman, UK, USA, China, India, Kenya. The INTERGROWTH-
21st Project’s main aim was to study growth, health, nutrition and 
neurodevelopment from less than 14 weeks and 0 days of gestation to 2 
years of age, so as to produce prescriptive growth standards to 
complement the existing WHO Child Growth Standards, and to develop a 
new phenotypic classification of the fetal growth restriction and preterm 
birth syndromes. The populations that contributed participants to the 
project were first selected at the geographical level and then at the 
individual level within each study site. At the population level, urban areas 
were identified where most deliveries occurred in health facilities. The 
areas had to be located at an altitude of 1600 m, the area had to have low 
levels of non-microbiological contamination such as pollution, domestic 
smoke, radiation, or any other toxic substances. For the fetal component 
of the study (FGLS) women were recruited with characteristics at low risk 
of abnormal growth (optimal health, nutrition, education, and 
socioeconomic status). For example, maternal height (≥153 cm), body-
mass index (BMI; ≥18.5 and <30 kg/m2), haemoglobin concentration 
(≥110 g/L), absence of medical conditions. The study methodology 
(ultrasound protocol, statistical analysis etc…) was set to have low risks of 
bias. For the neonatal study ‘FGLS-like’ newborns were selected to create 
neonatal charts. Results of the studies showed striking similarity in linear 
growth in children from the eight sites, thereby justifying pooling data to 
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construct one international growth standard from the antenatal period to 2 
years of age. 
The INTERGROWTH-21st Project has produced an integrated set of 
standards and tools for antenatal and postnatal care, early67 and late 
gestational age estimation,68 first-trimester fetal size,67 fetal growth35 and 
estimated fetal weight standards,69 symphysis-fundal height standards,70 
pregnancy weight gain standards,71 newborn size for gestational age,72 
postnatal growth of preterm infants.73  
Growth velocity charts and infant development at 2 years old standards 
are also under preparation.74 
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Appendix 2: Pregnancy dating by fetal crown–rump length: 
a systematic review of charts 
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ULTRASOUND AS A HEALTH CARE TECHNOLOGY 
 
 
Ultrasound technology is one of the most used heath care technology 
especially in pregnancy in view of the safety, low costs, diagnostic 
capability and operators and women acceptability. However, this 
technique is associated with variability and poor reproducibility especially if 
it refers to studies where there is lacking of appropriate methodology and 
quality control.36-38, 75 
Software for ultrasound images, volumes and video analysis have been 
developed to assist the operator in the use of ultrasound.76, 77 Currently, 
ultrasound assessment still requires a skilled and trained operator but the 
progress in this area can improve the training and ultrasound performance 
especially in remote areas and low income settings, reduce the human 
workload associated with quality control and assist in the diagnostic 
performance of skilled operators.  
Given the benefits of ultrasound imaging such as portability, real time 
acquisition and low costs compared to other imaging modalities, there is a 
great potential for this technology to be widely used in resource poor 
settings. A software for ultrasound video sequences analysis has been 
developed in collaboration with biomedical engineers (Appendix 3).78  
Ultrasound video clips were acquired placing the probe at the symphysis 
and running a sweep to the fundus in 86 pregnant women recruited in the 
FGLS of the INETRGROWTH-21st Project. The software was developed in 
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order to identify video sequences containing one of the following four 
structures: fetal abdomen, heart, head skull, and ‘other fetal structures’ 
(anatomical structure which did not fall into the other three classes). The 
applicability of this approach would be an assistance in diagnosing the 
fetal lie in utero. Fisher vector methodology to develop the software for 
ultrasound object representation was used in this study. Normally, dense 
feature extraction is used as many state of art image classification 
methods, where features of interest are computed on a dense grid rather 
than sparsely using an interest point detector on an image. Given the 
characteristics of ultrasound images where the level of shadows and 
speckles are variable Fisher vector analysis was instead evaluated in this 
study and compared with a traditional dense feature extraction method 
(Bag-of-Visual-Words). Fisher vector analysis proved to be more effective 
in identifying the correct video sequence than traditional methods (98.9% 
versus 87.1%).  
An automatic video acquisition analysis could potentially help in training, 
standardisation and quality control in basic obstetric ultrasound for 
evaluating for example in low income countries the fetal presentation and 
viability. Confirmation of pregnancy viability (presence of fetal cardiac 
activity) and diagnosis of fetal presentation (head or buttock in the 
maternal pelvis) are the first essential components of ultrasound 
assessment in obstetrics. The former is useful in assessing the presence 
of a viable pregnancy and the latter is essential for labour management. 
An automated framework for detection of fetal presentation and heartbeat 
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presence from a predefined “free hand” ultrasound sweep of the maternal 
abdomen is reported (Appendix 4). The framework consists of a 
classification regime for a frame by frame categorization of each 
bidimensional slice of the video. 323 videos of women taking part in the 
FGLS of the INTERGROWTH-21st Project were acquired in pregnancies 
beyond 28 weeks of gestation using the previous described approach 
(Appendix 3). Automatic software analysis is performed using multiple 
approaches in order to detect correctly one of the 4 video frame 
sequences of interest (head, heart, abdomen, other ultrasound structure 
background). The fetal skull, abdomen, and heart were detected with a 
mean classification accuracy of 83.4%. Furthermore, for the detection of 
the heartbeat presence an overall classification accuracy of 93.1% was 
achieved. 
 
Another area where software analysis can assist in fetal ultrasound is the 
automatic extraction of plane of interest from three-dimensional volumes. 
An automatic measurements tool with caliper placement on structures of 
interest can facilitate human workload, can be used for training purposes 
and quality control. In another study a learning-based solution to 
automatically determine anatomical views and head and brain structures 
measurements is reported (Appendix 5).79  
For the purpose of this study the three recommended planes for routine 
head biometry and fetal brain structures assessment were analysed: 
transthalamic (TT), transventricular (TV), transcerebellar (TC) plane.5 
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Recommended measurements for clinical use were selected: biparietal 
diameter (BPD), occipito-frontal diameter (OFD), and transcerebellar 
diameter (TCD). The model established anatomical correspondence 
between the detection of the plane and the placement of calipers for the 
measurements by the software compared with sonographers (manual 
annotations). 27 fetal head volumes from the FGLS of the 
INTERGROWTH-21st Project were analysed by 10 operators: three 
technical biomedical engineers experts in brain and volume analysis 
(expert level 1), four sonographers qualified in routine prenatal screening 
(expert level 2), and three clinicians specialised in fetal medicine trained 
and standardised in neurosonography (expert level 3). Each operator was 
asked to extract the appropriate planes and place the calipers for the 
relevant measurements. The reproducibility between different set of 
sonographers were reported analysing the angle of rotation and the offset 
of the plane extracted. Measurements reproducibility was assessed in mm. 
The automatic software plane detection and measurements reproducibility 
was better compared with sonographers manual annotation for each one 
of the expert level group. For example the average angle and offset of 
interobserver variability for TC plane were 4.71° and 1.2 mm for software 
analysis and 9.80° and 2.34 mm for manual annotation by the expert level 
3 group respectively. Similarly, the average TC and OFD measurements 
were 0.72 mm and 1.02 mm for software analysis and 1.16 mm and 0.83 
mm for manual annotation respectively. 
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Appendix 3: Fisher vector encoding for detecting objects of 
interest in ultrasound videos 
 
IEEE 12th International Symposium on Biomedical Imaging (ISBI) 2015. 
pp. 651-654 
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Appendix 4: A framework for analysis of linear ultrasound 
videos to detect fetal presentation and heartbeat 
 
 
 
 
   
 
69 
 
 
 
 
 
 
 
 
 
   
 
70 
 
 
 
 
 
 
 
 
 
   
 
71 
 
 
 
 
 
 
 
 
   
 
72 
 
 
 
 
 
 
 
 
   
 
73 
 
 
 
 
 
 
 
 
   
 
74 
 
 
 
 
 
 
 
 
   
 
75 
 
 
 
 
 
 
 
 
   
 
76 
 
 
 
 
 
 
 
 
   
 
77 
 
 
 
 
 
 
 
 
   
 
78 
 
 
 
 
 
 
 
 
   
 
79 
 
 
 
 
 
 
 
 
   
 
80 
 
 
 
 
 
 
 
   
 
81 
 
 
 
 
 
 
 
 
   
 
82 
 
 
 
 
 
 
 
 
 
 
   
 
83 
Appendix 5: Learning from redundant but inconsistent 
reference data: Anatomical views and measurements for 
fetal brain screening 
 
SPIE, Medical Imaging 2016: Image Processing, 97841A  
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QUALITY CONTROL IN FETAL ULTRASOUND 
 
 
Quality control in fetal ultrasound has been demonstrated to improve 
measurements variability and therefore is essential in assessing the 
growth of fetal structures and creating fetal biometry charts.41 Appropriate 
quality control strategies should include image storage, image reviewing 
and reproducibility assessment.42 Despite years of practice the use of a 
comprehensive quality control strategy is lacking in most of the studies 
aimed to create fetal charts.36-38 The review and judgment of ultrasound 
images is part of a standardisation process which contributes to the quality 
control strategy. The subjective assessment of an image (‘poor or good’) 
can affect the reproducibility between different observers. Furthermore, if 
not appropriate reproducibility tests are used results are not comparable. 
Different strategies have been tested in order to test reproducibility. The 
use of intraclass correlation coefficients is not the most appropriate 
method as it is a measure of agreement between different observers or 
different measurements methods rather than reproducibility. Two methods 
are the most appropriate to assess qualitative and quantitative 
reproducibility: the kappa coefficient (k) and the Bland- Altman plots 
respectively.80, 81       
The introduction of an objective assessment has been demonstrated to be 
more reproducible than subjective assessment in assessing fetal biometry 
images,82 CRL images (Appendix 6)83 and pulsed wave Doppler images 
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(Appendix 7).  CRL measurement images were assessed in 125 fetuses 
recruited into the FGLS of the INTERGOWTH-21st Project. Images were 
acquired according with specific criteria.84 Images were assessed by two 
observers using either a subjective evaluation consisting of rating an 
image as acceptable or unacceptable, or using an objective evaluation 
based on six criteria. Overall agreement between the observers was 
higher for objective evaluation (95.2%, adjusted k: 0.904), than for 
subjective evaluation (77.6%, adjusted k: 0.552) (Appendix 6).  A similar 
approach was used to assess the reproducibility of a proposed six points 
scoring criteria for pulsed wave Doppler images. 120 umbilical and uterine 
artery Doppler ultrasonographic images selected from the INTERBIO-21st 
Fetal Study (a multicentre, multiethinic study aimed to recruit high and low 
risk women to identify best predictors of abnormal pregnancy outcome) 
were assessed either using a subjective evaluation consisting of rating an 
image as acceptable or unacceptable or using the proposed objective 
evaluation. Overall agreement between assessors for the objective 
evaluation was higher (85%, adjusted k: 0.70), than for the subjective 
evaluation (73%, adjusted k: 0.47) (Appendix 7). 
The assessment of reproducibility provides useful in creating fetal 
biometry standards. In fetal ultrasound assessment this is particularly 
important as accuracy of a measurement methods cannot be ascertained 
(comparing ultrasound measurements against a ‘gold standard’). 
Pathology studies, comparison with other health technologies like 
magnetic resonance imaging or the use of phantoms are not reliable. The 
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solution highlighted in literature is to consider the most appropriate the 
method as that one with best reproducibility results.85 We performed a 
study aimed to identify the best method for fetal head circumference (HC) 
biometry measurements by ultrasound using the approach described 
above (Appendix 8).75 Different methods of calipers placement (BPD 
“outer to outer”, BPD “outer to inner”, OFD, HC using the ellipse facility) 
onto two different planes of acquisition (TT and TV) have been tested and 
reproducibility reported. 208 women recruited in the FGLS underwent 
extra measurements. More than 4400 measurements were taken. No 
major differences in reproducibility were observed with a standardised 
approach. The mean intraobserver and interobserver mean differences 
were < 1% (2.26 mm) and the 95% limits of agreement were < 8% (14.45 
mm) for all fetal head measurements obtained in TV and TT planes. As a 
conclusion BPD “outer to outer”, BPD “outer to inner”, OFD, and HC using 
the ellipse facility can be acquired both in the TT or the TV plane. The use 
of BPD “outer to outer”, OFD, and HC using the ellipse facility should be 
preferred as it allows fetal HC to be measured and compared with 
neonatal HC. TT plane is preferable as international standards in this 
plane are available; however, measurements in the TV plane can be 
plotted on the same standards. 
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Appendix 6: Image-scoring system for crown–rump length 
measurement 
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Appendix 7: Image-scoring system for umbilical and 
uterine artery pulsed wave Doppler measurement 
 
This is study is under the review of the Scientific Steering Committee of 
the INTERGORWTH-21st Project and it might undergo substantial review 
of the data before the publication in the journal peer reviewed process.  
 
ABSTRACT 
 
Objective: To develop an objective, image scoring system for pulsed wave 
Doppler measurement in obstetrics based upon six predefined criteria and 
evaluate how the system compares with subjective assessment. 
Methods: A total of 120 umbilical and uterine artery Doppler 
ultrasonographic images were randomly selected from the INTERBIO-21st 
Study database. Two assessors retrospectively evaluated the images 
objectively using the six-point image-scoring system and subjectively, in a 
blinded fashion. Subjective assessment consisted of classifying an image 
as acceptable or unacceptable. The percentage of agreement and a 
Kappa statistic of the two assessors were compared.  
Results: Overall agreement between assessors for the objective 
evaluation was higher (agreement=85%, adjusted k=0.70), than for the 
subjective evaluation (agreement=73%, adjusted k=0.47). The levels of 
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agreement for the six criteria were: anatomical site (adjusted k=0.97), 
sweep speed (adjusted k=0.88), magnification (adjusted k=0.77), velocity 
scale (adjusted k=0.68), image clarity (adjusted k=0.68), and angle of 
insonation (adjusted k=0.65). 
Conclusion:  
The proposed six-point image-scoring system for umbilical and uterine 
artery pulsed wave Doppler measurement is more reliable and 
reproducible than subjective evaluation. We suggest the system should be 
the preferred method for quality control, auditing and teaching.  
  
 
INTRODUCTION 
 
Doppler ultrasonography is a safe and non-invasive way of evaluating 
blood flow in vivo1, which plays an important role in identifying and 
managing pregnancies at greatest risk of preeclampsia, intrauterine 
growth restriction (IUGR), fetal distress in labour, and neonatal morbidity2. 
In pregnancies with suspected IUGR and/or hypertensive disease Doppler 
ultrasound is associated with a reduced number of perinatal deaths and 
unnecessary obstetric interventions3.  
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The International Society of Ultrasound in Obstetrics and Gynecology 
(ISUOG) practice guidelines for the use of Doppler ultrasonography in 
obstetrics recommend considering a number of factors to minimise 
measurement errors and improve reproducibility, including fetal breathing 
and body movements, colour flow mapping, optimal angle of insonation, 
horizontal sweep speed, gain, and pulsed wave frequency4.  
These factors aim to improve the reproducibility of measurements, and 
recognize the fact that imaging quality in Doppler is important: for example 
a change in the angle of insonation of only 10° corresponds to a 2% 
velocity error whilst a 20° angle corresponds to 6% error4. 
 
Nevertheless, despite widespread use, objective quality control criteria for 
the use of Doppler in pregnancy are lacking. Although different techniques 
and some optimum criteria have been described, we have been unable to 
find any previous studies on formal scoring systems or objective 
assessment. The use of scoring systems, for example in fetal biometry5, 
nuchal translucency or measurement of crown rump length6-9, have been 
demonstrated to be feasible and more reproducible between assessors 
than subjective assessment. This can play an important role in training, 
auditing and quality control of sonographers.  
The aim of this study was to develop an image-scoring system for Doppler 
ultrasound and to evaluate how it compares with a subjective assessment. 
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METHODS  
 
Stored images of uterine and umbilical artery pulsed wave Doppler 
assessment were obtained by the ultrasound quality control unit of the 
INTERBIO-21st Fetal Study (a study under the umbrella of the 
INTERGROWTH-21st Project)10, 11.  
The INTERBIO-21st Fetal Study is a multicentre, multiethnic, project 
conducted in centres taking part in the INTERGROWTH-21st Project and 
in other resource-poor setting countries, which aimed to evaluate newborn 
phenotypes so as to understand better the relationship between the 
causes of FGR and preterm birth syndromes. Data collected include 
maternal and neonatal biological samples, fetal ultrasound growth 
patterns, pregnancy and postnatal outcomes. Inclusion criteria in the 
INTERBIO-21st Fetal Study are reported elsewhere 
(www.interbio21.org.uk). Briefly, women were more than 18 years old with 
BMI < 35 and having natural conception. Pregnancies were dated 
according with crawn rump length (CRL) measurement between 9+0 and 
14+0 weeks. Serial bidimensional ultrasound scans were performed every 
5±1 weeks, from 14+0 to 41+6 weeks’ gestation, and images were stored 
for later analysis. Other than measurements obtained as in the FGLS of 
the INTERGROWTH-21st Project one uterine and umbilical artery pulsed 
wave Doppler measurement for each scan was obtained according to the 
corresponding FGLS Protocol and Ultrasound Operations Manual (the 
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INTERBIO-21st Consortium, INTERBIO-21st Study Protocol, Oxford, 
October 2012. (www.interbio21.org.uk)). 
 Women taking part in the INTERBIO-21st Fetal Study had Doppler 
assessment using commercially available ultrasound machines (Philips 
HD- 9, Philips Ultrasound, Bothell, WA, USA, equipped with curvilinear 
abdominal transducers: C5-2, C6-3 and V7-3 and GE Voluson E8, GE 
Healthcare, Zipf, Austria equipped with  RAB 4-8-D probe). Briefly, the 
protocol recommended using transabdominal ultrasound with appropriate 
setting adjustment. Assessment of uterine artery blood flow was 
performed between 19+0 and 23+6 weeks. The artery on each side was 
identified using color flow mapping at the apparent crossover with the 
external iliac artery. Pulsed wave Doppler was then used using an 
appropriate gate size and minimum angle of insonation to obtain 4 - 6 
similar waveforms. After angle correction, the Pulsatility index (PI), 
Resistance index (RI) are measured and presence of an early diastolic 
“notch” recorded for each vessel (defined as a clearly defined upturn of the 
flow velocity waveform at the beginning of diastole in all waveforms)12. For 
umbilical artery Doppler, carried out after 24 weeks, the signal was 
obtained from a free loop of the umbilical cord, ensuring fetal quiescence 
(absence of significant limb or breathing movements). Color Doppler was 
used to identify the vessel and the pulsed wave Doppler gate used to 
obtain 4 - 6 consistent waveforms. PI, RI, Systolic / Diastolic ratio (S/D) 
were measured via auto tracing of three or more consecutive similar 
waveforms, from the beginning of the systolic to the end of the diastolic 
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signal. In case where this was not possible, a manual trace can be used 
for these calculations. End diastolic flow (EDF) was reported as present, 
absent or reversed.  
  
The Doppler images were taken by trained sonographers in five different 
countries (Brazil, Kenya, South Africa, Pakistan and Thailand) who 
underwent a specific standardisation process similar to that for fetal 
biometry13. For the purposes of this study a pre-specified number of 
images were selected at random and retrieved from the database.  
Subjective and objective evaluation of all images was then performed by 
two independent assessors (A and B). The assessors were blinded to 
each other’s results and also to the sonographer who took the original 
image. For subjective evaluation the reviewers were asked to rate the 
images as either “acceptable” or “unacceptable” based on visual 
assessment. In the objective evaluation a new six-point image-scoring 
criterion was developed based on recommended and established 
standards for Doppler measurements4, 11, 12, (Table 1). Assessors gave 
one point to each criterion if it was satisfied and zero points if the criterion 
was not satisfied (Figure 1-4). Therefore the total maximum score an 
image could achieve was six. All criteria were accorded equal weight. Of 
note is that the main components of scoring criteria were a product of well 
established guidelines4. For the purpose of the comparison of the 
subjective versus the objective score, scores of 4-6 were considered as 
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“acceptable” while those scoring 3 or less were classed as “unacceptable” 
(Figure 5). 
 
 
Statistical analysis 
Based on findings from previous studies5, 14 we determined that a total of 
120 images would be needed to detect a 10% difference between two 
assessors with 90% power, assuming an inter-observer agreement rate of 
80%. 
Agreement between the two assessors based on subjective and objective 
results were assessed independently and also compared between them. 
Prevalence-adjusted, bias-adjusted kappa coefficients were used to 
determine the intra- and inter-assessor agreement between the objective 
score and subjective assessment.  
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RESULTS 
 
A total of 120 umbilical and uterine artery pulsed wave Doppler images 
were examined; both assessors were able to undertake the subjective and 
objective evaluation on all images. The percentage of agreement between 
two assessors was 73.3% for subjective and 85% for objective evaluation. 
For subjective assessment, 47 (39%) were classified as unacceptable by 
assessor A, 23 (19%) by assessor B and as a result 19 (15.8%) images 
classified as unacceptable by both assessors. This resulted in overall 
inter-reviewer agreement of 73.3% [adjusted kappa, 0.47 (95% CI, 0.31-
0.62)].  
In the images rated subjectively as acceptable by both assessors, all 
scored 3 and above in the respective objective assessment, with the 
majority scoring 5 and 6 (Table 2). Conversely, none of the images 
deemed subjectively unacceptable scored 6 in objective assessment and 
only one scored 5 in the objective assessment of reviewer B (Table 2). 
The inter-assessor agreement for objective rating was 85% [adjusted 
kappa, 0.70 (95% CI, 0.58 – 0.83)]. 
We also evaluated the degree of agreement for the individual criteria 
between the two assessors in the objective assessment. The 
interassessor agreement was highest for the anatomic site (98.3%) and 
sweep speed (94.2%) and lowest for the angle of insonation (82.5%) 
(Table 3). 
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DISCUSSION 
 
Pulsed waved Doppler measurement is used widely in clinical practice and 
of particularly importance in high risk pregnancies. The lack of 
standardisation and quality control in acquisition of Doppler data can lead 
to heterogeneous results and methodology bias in fetal ultrasound 
studies12, 15. Furthermore, the absence of a quality control can significantly 
affect the clinical practice6. 
Quality assessment of Doppler images can be undertaken subjectively, by 
judging an image to be acceptable or not; or objectively by using criteria 
that have been derived for this purpose. What we show in this study is that 
objective, criterion-based scoring has been demonstrated to be more 
reliable and reproducible than subjective evaluation, with the former 
associated with substantial agreement, rather than the moderate 
agreement with subjective evaluation16. This is an important finding as 
better quality assessment could allow better identification of sonographers 
who could benefit from further training and could allow focused feedback. 
Poor technique is unlikely to “normalise” raised uterine / umbilical PI (or 
indeed normalise absent or reversed end diastolic flow), but may make 
normal blood flow appear less normal. Therefore, the most likely impact of 
this may be in reducing the number of false positive (falsely abnormal) 
results. In addition, the adoption of objective quality control is likely to 
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reduce measurement variability, and this has been shown in other areas of 
ultrasound13.  
We found that with objective scoring the level of agreement was 
particularly high for assessment of anatomic site, sweep speed and 
magnification (adjusted kappa > 0.7); while it was good for the assessment 
of the angle of insonation, image clarity and velocity scale (adjusted 
kappa: 0.65, 0.68, 0.68, respectively). This was much lower with 
subjective scoring (adjusted kappa: 0.47). This is in keeping with previous 
studies that found objective scoring was more reproducible than subjective 
assessment in second-trimester fetal biometry, NT, nasal bone and CRL 
measurement5, 7, 8, 14, 17, 18. In the case of fetal biometry, a quality-control 
and standardisation process led to a measurable improvement in inter-
observer variability in the settings of a multicentre study13. 
Previous studies have demonstrated that use of umbilical artery Doppler in 
the management of pregnancies suspected with intrauterine growth 
restriction and or hypertensive disease of pregnancy may reduce the 
number of perinatal deaths and unnecessary obstetric interventions19. 
Similarly, uterine artery Doppler screening is effective at predicting 
pregnancies at risk of adverse outcome and in selecting cases for more 
intense surveillance20, 21. In view of this, the accurate measurement of 
pulsed-waved Doppler for umbilical and uterine artery takes a particular 
importance. We believe that the scoring system used in this study is 
simple enough for clinical use, and it was derived from well established 
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guidelines4. It can be used easily in ultrasound departments for teaching, 
auditing and quality control.  
Our study was well powered to detect a significant difference. It was from 
a large, multicentre population and performed by trained sonographers 
who were blind to each other and to the reviewers. Adjusted kappa was 
used to minimise bias and to give a more reliable agreement for the 
criteria used in subjective or objective assessment22. 
There are limitations of this study. In the objective assessment all criteria 
had the same weight in the final score; it is likely that there are some 
parameters that are more important than others in ensuring a satisfactory 
Doppler signal. However, a complicated scale that uses different weighting 
of criteria must be balanced by the ease of application in daily practice. 
Another limitation is that there is a possibility that during the time interval 
between the color flow image being frozen and freezing of the final pulsed 
Doppler signal, movements might have taken place that could have 
changed the ultimate angle of insonation.  
We believe that in addition to a criterion-based scoring system advice 
given, to optimise the Doppler measurement, must be adhered to. This 
includes performing assessments during fetal quiescence; reduction of 
gate size to avoid sampling adjacent vessels4. 
We also realise that in this study we used cut-offs of continuous variables 
to dichotomise into acceptable or unacceptable. As an example, the angle 
of insonation is a continuous variable and quality is related to the angle 
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with the aim to use the smallest possible angle; yet we divide it by sing an 
angle above or below a certain threshold. This may have led to 
disagreement between subjective impression and objective measurement. 
However, use of such cut-offs was in keeping with the aim to derive a 
practical system based on accepted guidelines. 
As a result, we propose that our six-criterion objective quality-scoring 
system is used for the assessment of the images of the fetal pulsed wave 
Doppler measurements. Such objective assessment is more reliable and 
reproducible than subjective impression and should form the basis for 
quality control, teaching and auditing.  
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Table 1: Image-scoring criteria for umbilical and uterine artery Doppler 
measurement.       
                                                                                                  
Criteria Description 
Magnification  50% of the screen with zoom box and sample 
gate in the centre of the vessel 
Angle of insonation  less than 30o 
Sweep speed                             4 - 6 waveforms with consistent and similar 
signal                                          
Clarity of the image  Pulse rate frequency and color gain 
correction (avoid venous signal)                                                  
Anatomic site of the sample  Umbilical artery: free loop   
Uterine artery: before the bifurcation above 
the iliac vessels 
Velocity scale                 75% of the peak systolic velocity              
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Table 2: Distribution of objective image score for each subjective image 
rating for pulsed wave Doppler measurement for reviewers A and B.                                                                             
 
 Objective image score 
Subjective scoring 1 2 3 4 5 6 
Unacceptable  A      1 (0.8) 5 (4.2) 16 (13.3) 16 (13.3) 6 (5) 3 (2.5) 
Acceptable  A                          - 1 (0.8) 10 (8.4) 17 (14.2) 29 (24.2) 16 (13.3) 
Unacceptable  B - 1 (0.8) 15 (12.5) 6 (5) 1 (0.8) - 
Acceptable  B                    - - 11 (9.2) 25 (20.8) 41 (34.2) 20 (16.7) 
Unacceptable by both A and B, 
Objective scoring for  A  
1 (5.26) 
 
5 (26.32) 9 (47.37) 4 (21.05) - - 
Unacceptable by both A and B,  
Objective scoring for  B 
- 1 (5.26) 11 (57.89) 6 (31.58) 1 (5.26) - 
Acceptable by both A and B,       
Objective scoring for  A 
- - 7 (10.14) 16 (23.19) 29 (42.03) 17  (24.64) 
Acceptable by both A and B,                                      
Objective scoring for  B 
- - 7 (10.14) 14 (20.29) 32 (46.38) 16 (23.19) 
 
A: Operator A, B: Operator B, data given n (%) 
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Table 3: Adjusted kappa and percentage of agreement for individual 
criteria of pulsed wave Doppler assessment. 
                                                                                            
Criterion       Adjusted kappa (95% CI) Agreement (%)                                                                                            
Magnification                                                                          0.77 (0.65-0.88) 88.3% 
Angle of insonation                                                                0.65 (0.52-0.78) 82.5% 
Sweep speed                                                                           0.88 (0.80-0.97) 94.2% 
Image clarity                                                                            0.68 (0.56-0.81) 84.2% 
Anatomic site                                                                          0.97 (0.92-1.01) 98.3% 
Velocity scale                                                                          0.68 (0.55-0.81) 84.2% 
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Figure 1: Image showing the correct way of measuring the umbilical artery 
Doppler. 
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Figure 2: Image of umbilical artery Doppler demonstrating poor 
magnification; the velocity scale is less than 75% and sweep speed is 
more than 4-6 waveforms. 
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Figure 3: Image showing the measurement of uterine artery Doppler in 
the correct way. Note that the angle of insonation has been corrected. 
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Figure 4: Image showing uterine artery Doppler measurement 
demonstrating poor magnification and an angle of insonation greater than 
30 degrees. 
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Figure 5: Frequency distribution of objective scoring for the two operators. 
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Appendix 8: Scientific basis for standardization of fetal 
head measurements by ultrasound: a reproducibility study 
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Table S1 Studies reporting on quantitative reproducibility of fetal head biometry identified in literature search 
 
Only the first author of each study is given. *Only study reporting occipitofrontal diameter (OFD) mean difference in intraobserver reproducibility in the second trimester (2T) (1.26 mm) and 
third trimester (3T) (1.46 mm). †Biparietal diameter outer-to-inner (BPDoi). ‡Biparietal diameter outer-to-outer (BPDoo). 1T, first trimester; BA, Bland–Altman plot; BPD, biparietal diameter; 
CP, caliper placement; GA, gestational age; HC, head circumference; Inter., interobserver reproducibility; Intra., intraobserver reproducibility; NA, not available; Op, operator; TT, 
transthalamic plane; TV, transventricular plane. 
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Figure S1 Bland–Altman plots showing intraobserver reproducibility for Sonographers A and 
B of outer-to-outer and outer-to-inner caliper placement when measuring biparietal diameter 
(BPD)  in the transthalamic plane. Plots on left show absolute difference (in mm) and plots on 
right show reproducbility as a percentage.  
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Figure S2 Bland–Altman plots showing interobserver reproducibility of outer-to-outer and 
outer-to-inner caliper placement when measuring biparietal diameter (BPD) in the 
transthalamic plane. Plots on left show absolute difference (in mm) and plots on right show 
reproducbility as a percentage. 
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Figure S3: Bland–Altman plots showing intraobserver reproducibility, in the transthalamic and 
transventricular planes, of acquiring and measuring head circumference using the ellipse 
facility (HCellipse), biparietal diameter (BPD), occipitofrontal diameter (OFD) and head 
circumference calculated from the two perpendicular head diameters BPD and OFD 
(HCcalculated). Plots on left show absolute difference (in mm) and plots on right show 
reproducbility as a percentage. 
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 Figure S4: Bland–Altman plots showing interobserver reproducibility, in the transthalamic 
and transventricular planes, of acquiring and measuring head circumference using the ellipse 
facility (HCellipse), biparietal diameter (BPD), occipitofrontal diameter (OFD) and head 
circumference calculated from the two perpendicular head diameters BPD and OFD 
(HCcalculated). Plots on left show absolute difference (in mm) and plots on right show 
reproducbility as a percentage. 
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Figure S5: Bland–Altman plots showing interobserver reproducibility of caliper replacement, 
in transthalamic and transventricular planes, for measuring head circumference using the 
ellipse facility (HCellipse), biparietal diameter (BPD), occipitofrontal diameter (OFD) and head 
circumference calculated from the two perpendicular head diameters BPD and OFD 
(HCcalculated). Plots on left show absolute difference (in mm) and plots on right show 
reproducbility as a percentage. 
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Figure S6: Bland–Altman plots showing between-plane intraobserver reproducibility 
in the transthalamic and transventricular planes, of acquiring and measuring the head 
circumference using the ellipse facility (HCellipse), biparietal diameter (BPD), 
occipitofrontal diameter (OFD), head circumference calculated from the two 
perpendicular head diameters (HCcalculated). Plots on left show absolute difference (in mm) 
and plots on right show reproducbility as a percentage. 
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Figure S7: Bland–Altman plots showing between-plane interobserver reproducibility in transthalamic 
and transventricular planes, of acquiring and measuring head circumference using the ellipse facility 
(HCellipse), biparietal diameter (BPD), occipitofrontal diameter (OFD), head circumference calculated from 
the two perpendicular head diameters BPD and OFD (HCcalculated). Plots on left show absolute difference 
(in mm) and plots on right show reproducbility as a percentage. 
Mean =  -0.65mm
+1.96SD = 12.61mm
-1.96SD = -13.90mm
-2
0
-1
5
-1
0
-5
0
5
1
0
1
5
2
0
D
if
fe
re
n
c
e
 (
m
m
)
100 150 200 250 300 350 400 450
Average (mm)
Mean = -0.10%
+1.96SD = 5.01%
-1.96SD = -5.21%
-1
0
-5
0
5
1
0
%
 d
if
fe
re
n
c
e
 (
d
if
fe
re
n
c
e
/a
v
e
ra
g
e
)
100 150 200 250 300 350 400 450
Average (mm)
 
Mean = 0.02mm
+1.96SD = 3.77mm
-1.96SD = -3.74mm
-1
0
-8
-6
-4
-2
0
2
4
6
8
1
0
D
if
fe
re
n
c
e
 (
m
m
)
30 50 70 90 110 130
Average (mm)
Mean = 0.24%
+1.96SD = 6.07%
-1.96SD = -5.60%
-1
5
-1
2
-9
-6
-3
0
3
6
9
1
2
1
5
%
 d
if
fe
re
n
c
e
 (
d
if
fe
re
n
c
e
/a
v
e
ra
g
e
)
30 50 70 90 110 130
Average (mm)
 
Mean =  -0.24mm
+1.96SD = 7.73mm
-1.96SD = -8.21mm
-2
0
-1
6
-1
2
-8
-4
0
4
8
1
2
1
6
2
0
D
if
fe
re
n
c
e
 (
m
m
)
30 50 70 90 110 130 150
Average (mm)
Mean =  -0.14%
+1.96SD = 7.97%
-1.96SD = -8.25%
-1
5
-1
2
-9
-6
-3
0
3
6
9
1
2
1
5
%
 d
if
fe
re
n
c
e
 (
d
if
fe
re
n
c
e
/a
v
e
ra
g
e
)
30 50 70 90 110 130 150
Average (mm)
 
Mean =   -0.34mm
+1.96SD = 14.12mm
-1.96SD = -14.81mm
-2
0
-1
5
-1
0
-5
0
5
1
0
1
5
2
0
D
if
fe
re
n
c
e
 (
m
m
)
100 150 200 250 300 350 400 450
Average (mm)
Mean = 0.03%
+1.96SD = 5.53%
-1.96SD = -5.47%
-1
0
-5
0
5
1
0
%
 d
if
fe
re
n
c
e
 (
d
if
fe
re
n
c
e
/a
v
e
ra
g
e
)
100 150 200 250 300 350 400 450
Average (mm)
 
Between planes interobserver 
reproducibility for BPD  (mm) 
 
Between planes interobserver 
reproducibility for HCellipse  (%) 
 
Between planes interobserver 
reproducibility for HCellipse (mm) 
 
Between planes interobserver 
reproducibility for BPD (%) 
 
Between planes interobserver 
reproducibility for OFD  (mm) 
 
Between planes interobserver 
reproducibility for OFD  (%) 
 
Between planes interobserver 
reproducibility for HCcalculated (mm) 
 
Between planes interobserver 
reproducibility for HCcalculated (%) 
 
   
 
144 
FETAL BRAIN STRUCTURES SIZE CHARTS  
 
 
Central nervous system of the fetus is routinely assessed by ultrasound 
antenatally mainly to diagnose fetal anomalies and provide a useful tool to 
estimate the gestational age late in pregnancy. Central nervous system 
anomalies are a major component of fetal abnormalities detected antenatally.2  
Main assessment of fetal brain structures is performed using a subjective 
analysis of the morphology and a quantitative assessment using structures 
biometry. The latter provided to be a more objective method, with higher 
reproducibility,41, 86 and allowing quantitative calculation to assess the relative 
growth of brain structures with advancing gestation.5  
The use of the appropriate chart is therefore essential in research and clinical 
practice, whereas the use of different reference charts can affect the 
diagnostic ability of ultrasound in detecting fetal abnormality, can affect clinical 
decision and impair generalisability of results from research studies using 
different cut-offs.  
A systematic review of the literature has been performed to identify all the 
studies aimed to create brain structures charts. Only studies reporting on six 
specific fetal brain structures of relevant clinical interest obtained on axial 
planes were included in the final analysis (the parieto-occipital fissure (POF) 
and the sylvian fissure (SF) in the TT plane; the anterior ventricle (AV) and the 
posterior ventricle (PV) in the TV plane; the transcerebellar diameter (TCD) 
and cisterna magna (CM) in the TC plane).  
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Four major electronic databases (MEDLINE, EMBASE, Cochrane Library and 
Science Citation Index & Conference Proceedings Citation Index) were 
systematically searched from 1946 to June 2016. Only articles written in 
English were considered. Article reporting on animal studies, case reports, 
food, comments, letters, editorials were excluded. A search strategy was 
formulated in collaboration with a professional information specialist. The 
following keywords were entered: fetal or foetal or fetus or foetus AND 
ultrasound or ultrasonogra* or ultra-sonogra* or sonic* or scan* AND brain or 
cerebral ventricles or lateral ventricles or cisterna magna or cranial fossa, 
posterior or exp cerebellum OR  brain or cerebell* or transcerebell* or cerebral 
OR cerebellar or transcerebellar or cerebellum or cerebral cortex OR posterior 
fossa or cisterna magna OR sylvian fissure or lateral sulcus or lateral fissure 
or perisylvian cortex or cereb* fissure or brain fissure or parietooccipital 
fissure or parieto-occipital fissure or parietooccipital sulcus or parieto-occipital 
sulcus OR lateral ventric* OR brain or cereb* or lateral anterior or posterior 
AND embryonic and fetal Development or fetal development or gestational 
age AND reference standards or reference values OR reproducibility of results 
OR predictive value of tests OR observer variation OR reference or normal 
OR reference or growth OR correlat* or reproducib* or variation or validat* OR 
nomogram or nomograph OR biometry or biometric OR percentile or centile. 
More than 570 articles were identified after removal of duplicates. 95 articles 
underwent abstract and full paper review and 36 studies were finally 
identified.43-52, 87-112 There is substantial heterogeneity in the methodology 
used. High risk of bias in several domains have been identified including the 
selection of the population, the ultrasound protocol and the analysis of the 
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data. Less than 10% of the identified studies reported on maternal and fetal 
inclusion criteria, pregnancy outcome, ultrasound quality control and statistical 
description. Most importantly, no studies reported on long term infant 
outcome, most probably due to the retrospective descriptive design of data 
collection which was non-specific for the purpose of the study. Not 
surprisingly, these are common finding in creating fetal biometry charts as 
found in previous systematic reviews.36, 38 
To overcome such limitations in previous studies, the main aim of this project 
is to create international standards for six fetal brain structures by antenatal 
ultrasound. 
The study was conducted in women taking part in the INTERGROWTH-21st 
Project whose babies have a low risk of FGR and consequently low risk of 
abnormal neurological outcome. This is confirmed in the study findings as 
more than 99% of the babies with known motor development were normal at 1 
year of age.  
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Appendix 9: Normal fetal brain structures size: standards based on 
ultrasound measurements from the Fetal Growth Longitudinal Study of 
the INTERGROWTH-21st PROJECT. 
 
 
This is study is under the review of the Scientific Steering Committee of the 
INTERGROWTH-21st Project and it might undergo substantial review of the 
data before the publication in the journal peer reviewed process.  
 
ABSTRACT  
 
Objective: To create prescriptive growth charts of six fetal brain structures 
measured by ultrasound from the optimally grown fetal population of the 
INTERGROWTH-21st Project.  
Methods: This was a prospective multiethinic multicentre cross-sectional study 
aimed to assess the size of parieto-occipital fissure (POF), sylvian fissure 
(SF), anterior ventricle (AV), posterior ventricle (PV), transcerebellar diameter 
(TCD) and cisterna magna (CM) in planes reconstructed from head volumes 
acquired from women at low risk of abnormal fetal growth and perinatal 
complications. Fetuses were randomly recruited ensuring an equal distribution 
between the 8 countries of origin and week of gestation (range: 15 - 36 
weeks). Children long term follow up was assessed by motor assessment at 1 
year of age. The best fitting powers were provided by second-degree 
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fractional polynomials and further modelled in a multilevel framework to 
account for the cross-sectional design of the study.  
Results: 451 fetuses were recruited and after exclusions a total of 442 
volumes from live singletons without congenital malformations were used to 
create the charts. Motor assessment was available in 297 cases and it was 
normal in 98% of them. Structures were measurable in 90% of cases. Mean 
and standard deviations observed were 5.47 (1.91), 9.45 (4.22), 7.61 (1.54), 6 
(1.59), 28.97 (9.32), 5.27 (1.66) mm for the POF, SF, AV, PV, TC and CM 
respectively, showing increasing size (all) and variability (POF, SF, PV, TCD, 
CM) with advancing gestation. 5th, 50th, 95th smoothed centile were 
calculated. 
Conclusions: Prescriptive brain structures size charts were created from 
fetuses at low risk of long term abnormal development. The proposed charts 
should be recommended as international standards for fetal brain structures 
measurements by ultrasound.  
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INTRODUCTION  
 
During pregnancy, the anatomy of the development of the fetal brain can be 
assessed using ultrasound. On most settings this is undertaken as part of a 
routine assessment of the fetal anatomy at around 20 weeks of gestation, and 
the main aims are to demonstrate anatomical integrity; and to diagnose 
abnormalities of the central nervous system (CNS). Such anomalies can be 
visualised directly (for example absence of a structure, such as the corpus 
callosum); or indirectly (such as a banana shaped cerebellum in open spina 
bifida). Measurement of intracranial structures forms part of this, and often 
includes assessment of the head size; width of the atrium of the posterior 
ventricle; cerebellar diameter and cisterna magna.1 In more advanced 
neurosonography, undertaken due to indications such as previous or 
suspected abnormality, measurements of other structures or at different 
gestations is also practiced – either earlier in gestation such as in cases of 
previous history, or late in gestation, assessing for instance gyration and 
sulcation patterns.2-6 Measurement of structures can also be assessed 
antenatally to estimate gestational age.7 
Because subjective evaluation of fetal brain structures is associated with high 
variability,8 quantitative estimation using biometric measurements are 
generally used; however, there are several limitations of existing charts.9-16 
This may contribute to variability of interpretation of ultrasound diagnosis of 
CNS abnormalities.17 
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In some sense, these aspects are generic to ultrasound measurement. A 
similar lack of a standard approach due to use of different reference charts 
has also been observed in fetal biometry and pregnancy dating.18, 19 In 
addition, the recommendation for evaluation using a prescriptive approach 
(using standards) rather than descriptive approach (using references) has led 
us to produce international standards for pregnancy dating, fetal growth and 
other aspects of pregnancy care.20-23 
To complement these products we present here standards for size estimation 
of six fetal brain structures in a multiethnic population of healthy women taking 
part in the INTERGROWTH-21st Project whose babies have a low risk of 
abnormal developmental outcome.  
 
 
METHODS 
 
Study population 
The study was performed in women recruited as part of INTERGROWTH-21st 
Project (www.intergrowth21.org.uk), a multicentre, multiethnic, population-
based project, conducted between 2008 and 2013 in eight countries. The 
Fetal Growth Longitudinal Study (FGLS) involves both two-dimensional and 
three-dimensional serial fetal scans performed every 5 weeks from 14+0 to 
41+6 weeks.21 Women participating in this study have low-risk pregnancies 
that fulfil well defined and strict inclusion criteria at recruitment.24 Briefly, 
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inclusion criteria were maternal age between 18 and 35 years, body mass 
index (BMI) ≥18.5 and <30 kg/m2, a singleton pregnancy, normal pregnancy 
history without relevant past medical history, no evidence of socioeconomic 
constraints likely to impede fetal growth, no use of tobacco or recreational 
drugs and no heavy alcohol consumption. Women also had to have a known 
date of last menstrual period (LMP) with regular cycles without hormonal 
contraceptive use or breastfeeding during the 2 months before pregnancy and 
natural conception; gestational age was based on LMP if standardized 
ultrasound measurement of crown–rump length between 9+0 and 14+0 weeks 
was in agreement within 7 days.25 
Detailed pregnancy outcomes, and where available, motor assessment at age 
1 year are reported. One-year follow up of infants was collected by interview 
of parents or assessment by a certified examiner. Achievement of milestones 
(sitting without support, standing with assistance, hand-and-knees-crawling, 
walking with assistance, standing alone and walking alone) were considered 
normal if the proportion of babies achieving milestones was similar to 
expected windows of achievement (less than the 99th centile child age for 
each of the expected windows).26  
All ultrasound scans were performed by sonographers trained, standardised 
and regularly audited according to the FGLS standards.27, 28 The same 
commercially available ultrasound machine (Philips HD-9, Philips Ultrasound, 
Bothell, WA, USA) with curvilinear abdominal two-dimensional transducers 
(C5-2, C6-3) and one curvilinear abdominal three-dimensional transducer (V7-
3) was used for all growth scans. For the purposes of the INTERGROWTH-
21st Project, the manufacturer reprogrammed the machine’s software to 
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ensure that the measurement values do not appear on screen during the 
scan, in order to reduce operator “expected value” bias. The 
INTERGROWTH-21st Project was approved by the Oxfordshire Research 
Ethics Committee “C” (ref: 08/H0606/ 139); all the pregnant women involved 
gave informed written consent.  
Three-dimensional ultrasound volumes of the fetal head were selected using 
computer randomisation from pregnancies recruited into the FGLS and 
ensuring an equal distribution between country of origin and gestational age 
week between 16 and 36 weeks.  
 
Structures measured, volume manipulation and measurement methodology 
Based on an extensive scoping exercise; review of the literature; and a pilot 
study involving 90 volumes, we aimed to create standards for three commonly 
used brain structures, namely the PV, TCD and CM1 and three other, clinically 
relevant structures that may be relevant in an extended examination (POF, 
SF, AV).9, 10, 13, 14, 29 These fetal brain structures were measured on still 
images retrieved from three-dimensional head volumes acquired in all eight 
recruiting units participating in the main study (Brazil, Italy, Oman, UK, USA, 
China, India, Kenya). 
Detailed definitions of the methodology for volume acquisition are provided 
elsewhere.27, 30 Briefly, head volumes were acquired at the level of the axial 
transthalamic plane. Six predefined quality control criteria for the 
transthalamic plane had to be satisfied to acquire the volume (Table 1) (Figure 
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1).28 Acquisition was undertaken with the volume data box and angle of 
sweep (usually 70 degrees) adjusted to include the entire skull; during fetal 
quiescence; with the mother asked to hold her breath; and with the transducer 
held steady. The real time image was observed during acquisition to confirm 
that the sweep included the entire skull with no maternal or fetal movement 
during the sweep, otherwise the process was repeated. All data were then 
sent to the coordinating unit in Oxford. 
 Offline analysis was undertaken by four experienced sonographers at the 
coordinating unit, who were trained and standardised in volume manipulation 
and fetal neurosonography. Volume manipulation for plane reconstruction and 
measurements were performed using the manufacturer software of the 
ultrasound machine or using the open-source image analysis software 
program MITK (Medical Imaging Interaction Toolkit MITK, version 0.12.2, 
German Cancer Research Center, Division of Medical and Biological 
Informatics, www.mitk.org).31 First, stored volumes of the fetal head were 
upload onto the multiplanar mode facility. Second, three standard two-
dimensional fetal brain measurement planes were extracted from each 
volume, namely the transventricular, transthalamic and transcerebellar planes. 
As the transthalamic plane was the plane of volume acquisition, it required 
minimum manipulation for the relevant structures to be visualised and was 
chosen for the measurements of the fissures. Starting from this plane, the 
operator rotated or scrolled the volume in orthogonal planes with the fulcrum 
or rotation primarily in the middle of the cavum of the septi pellucidi.11, 32 A 
movement to a more cranial level resulted in the transventricular plane, with 
the lateral ventricles located symmetrically on each side of the midline, the 
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anterior and posterior horns both visible, and the posterior ventricle cavity 
visualised as a hypoechoic structure (Figure 1).33 By rotating the volume onto 
the Y axis the transcerebellar plane was visualised including the cerebellum at 
its largest diameter (Figure 1).29  
Image quality criteria were used to ensure the maximum possible standard for 
each extracted plane (Table 1) before measurement of the following six 
structures: the parieto-occipital fissure (POF) and the sylvian fissure (SF) in 
the transthalamic plane; the anterior ventricle (AV) and the posterior ventricle 
(PV) in the transventricular plane; the transcerebellar diameter (TCD) and 
cisterna magna (CM) in the transcerebellar plane.  
 
Caliper placement for measurement acquisition 
The POF, the SF, the AV and the PV were measured in the distal hemisphere 
of the respective plane (due to the lower resolution in the proximal 
hemisphere). The POF was measured by placing the caliper form the inner 
edge of the falx to the inner edge of the fissure (‘inner to inner’) at its widest 
point, parallel to the biparietal diameter (modified from Alves et al.)9 The SF 
was measured from the lateral edge of the roof of the fissure to the medial 
edge of the skull at its widest point, parallel to the biparietal diameter (‘inner to 
inner’).13 Calipers for the AV were positioned between the internal margin of 
the midline falx and the lateral wall of anterior horn (‘inner to inner’).14 Calipers 
for the PV were positioned between the internal margin of the medial and 
lateral wall of the ventricle cavity (‘inner to inner’), at the level of the glomus of 
the choroid plexus, on an axis perpendicular to the long axis of the lateral 
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ventricle (Figure 1).29 The TCD was measured in the transcerebellar plane, 
perpendicular to the falx, with the calipers placed “outer to outer” between the 
distal margins of the hemispheres at the largest transverse diameter of the 
cerebellum.34 The CM was measured in the transcerebellar plane by placing 
the calipers from the posterior wall of the cerebellum at a level middle to the 
vermis to the inner wall of the skull (‘inner to inner’) (Figure 1).29 
 
Reproducibility 
This was assessed in a subset of 90 volumes. The first sonographer uploaded 
the volume, extracted the three planes and measured the six structures twice 
(intraobserver reproducibility for plane reconstruction and measurement 
acquisition). A second sonographer, re-upload the same volume and repeated 
this process (interobserver reproducibility for plane reconstruction and 
measurement acquisition). To assess the contribution of caliper replacement, 
the second sonographer replaced the calipers on still images and repositioned 
them to measure all structures in each plane stored by the first sonographer 
(interobserver reproducibility for calipers replacement on stored images). All 
sonographers were blinded to their own and the others measurements during 
the reproducibility study but also the main study. 
 
Statistical analysis 
The sample size was based on pragmatic and statistical considerations; the 
former was based on time frame necessary to obtain all the measurements 
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from the volumes (20 minutes); the latter focused on the precision at the 5th 
or the 95th centile, and regression-based reference limits. A sample of 300 
scans would obtain precision of 0.1 SD at the 5th or the 95th centile.35 
Assuming a rate of exclusion of 5% and working on a conservative estimate 
that in 40% of the volumes at least one structure would not be measureable 
(the upper limit of the confidence interval estimated from the pilot study, 
primarily due to missing data and movement artefact), it was estimated that 
441 volumes would lead to a minimum of 300 volumes analysed. In the event, 
the actual number measurable was higher than this.  
After comparing results from the various approaches, there was no evidence 
to support a non-normal distribution for a specific gestational age. The study 
was cross-sectional as volumes were analysed once. Goodness of fitness 
was assessed by Q-Q plots and a scatter plot of Z-scores by GA. Mean 
differences between the observed and fitted centiles were also calculated.  
For the reproducibility study, Bland-Altman plots were used to estimate mean 
systematic differences and 95% limits of agreement. Differences between and 
within observers were expressed in absolute values (mm) for the POF, SF, 
AV, PV and CM; while they were expressed as a percentage of fetal 
dimensions for the TCD, to take account of the increase in cerebellar size with 
gestational age. Percentages were calculated as the difference between two 
measurements divided by the average of the two measurements multiplied by 
100. All analyses were performed using STATA 11 (StataCorp, College 
Station, Texas, USA). 
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RESULTS 
 
A total of 451 volumes were selected and after exclusions a total of 442 
volumes used to reconstruct planes and create the charts (Figure 2). No 
congenital malformations were detected either antenatally or postnatally. 
Maternal demographics and pregnancy outcomes were similar to the overall 
FGLS population, confirming a low risk of perinatal complications (Table 2).  
Follow up of infants by interview of parents was available in 297 out of 442 
cases (67%), and 289 infants were assessed by a certified examiner (65%) at 
1 year (mean 12.3 months, range 10.9 - 19.4). Motor assessment reported by 
parents was normal in 99% of the infants, with milestone not achieved (>99th 
centile of the window of achievement) in 3 (1%), 3 (1%), 0, 0, 0, 0  infants for 
sitting without support, standing with assistance, hand-and-knees-crawling, 
walking with assistance, standing alone and walking alone respectively. There 
was overall good agreement between the achievements of milestones 
reported by parents compared to examination (average agreement 96%, 
range 92 to 100%). Reassuringly, in almost all cases where disagreement 
was present, the examiner reported more precocious milestone achievement 
than that reported by the parents, confirming the low risk for abnormal long 
term outcome in our cohort.  
 
In total, 2439 measurements of fetal brain structures were acquired. On 
average structures were optimally measurable in a high quality extracted 
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plane in 90% of cases, with the CM being the structure least frequently 
measurable. After removal of outliers measurements were available to create 
centiles for POF, SF, AV, PV, TC and CM in 420 (95%), 404 (91.4%), 370 
(83.7%), 422 (95%), 390 (88.2%), 352 (79.6%) cases respectively.   
The time required for analysis and structures measurement of a single volume 
was 9 ± 0.8 SD minutes (pilot study). Mean and SD of each measurement in 
mm were 5.47 (1.91), 9.45 (4.22), 7.61 (1.54), 6 (1.59), 28.97 (9.32), 5.27 
(1.66) for the POF, SF, AV, PV, TC and CM respectively. 
The gestational age-specific 5th, 50th, and 95th smoothed centiles for POF, 
SF, AV, PV, TCD and CM are presented in Figure 3. 5th, 50th, and 95th 
centiles according to gestational age for these ultrasound measures were 
calculated and reported in Supplementary Table 1. 
Goodness of fit by gestational age-specific comparisons of empirical centiles 
to smoothed centile curves (3rd, 50th, and 97th centiles) and comparing Z-
scores showed good agreement. Mean differences between the observed and 
smoothed centiles for the 3rd, 50th, and 97th centiles, respectively, were 
small: 0.22 mm (0.5), 0 mm (0.4), 0.17 mm (0.6) for the POF, 0.02 mm (1.1), 
0.03 mm (0.7), 0.09 mm (1.1) for the SF, 0.19 mm (0.8), 0.01 mm (0.4), 0.12 
mm (0.7) for the AV, 0.22 mm (0.8), 0.07 mm (0.5), 0.04 mm (0.8) for the PV, 
0.52 mm (1.6), 0.09 mm (1.1), 0.51 mm (2.6)  for the TCD and 0.1 mm (0.36), 
0.05 mm (0.4), 0.01 mm (0.9) for the CM .  
The equations for the mean and standard deviation from the multilevel 
regression models for each structure measure are presented in Table 3, 
allowing for calculations by readers of any desired centiles according to 
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gestational age in exact weeks. The best fitting powers were provided by 
second-degree fractional polynomials and further modelled in a multilevel 
framework to account for the cross-sectional design of the study. 
The actual values for these centiles according to gestational age are 
presented in Supplementary Table 1.  
As regards the reproducibility study, the mean difference and 95% limits of 
agreement are shown in Table 4. All measurements were reproducible within 
less than 3mm or 12% (all mean differences were less than 0.1mm and 
0.5%). The greatest proportion of variability was due to caliper replacement 
accounting for more than 50% of the intra- and interobserver variability for all 
structures.   
 
 
DISCUSSION  
 
In this study we have produced international standards for ultrasound 
measurements of brain structures, derived from a multi-ethnic population from 
the FGLS of the INTERGROWTH-21st Project. The design was prescriptive 
and selected a population of healthy, well nourished pregnant women and 
their fetuses and newborn babies.21 The populations were at low risk of 
obstetric complications and motor assessment at 1 year in keeping with 
expected norms (Table 2).  
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We used international guidelines to obtain measurements of the TCD, the CM 
and the PV;1, 29 as we were unable to find accepted guidelines on 
measurement of the depth of the SF or the POF, we developed methods for 
this. 
 Previous studies on the subjective assessment of brain fissures report 
variable results in terms of reproducibility (Kappa coefficients varying from 
0.56 to 0.95).8, 36 One aim of our international standards is to reduce the 
variability from such subjective non-quantitative assessment of fetal brain size 
and development.8, 37, 38 
One of the pitfall in neurosonographic subjective assessment is in the 
absence of plane standardisation. Using different planes in fetal head 
biometry can lead to significant measurement difference.33 In some studies 
landmarks for plane acquisition are not specified,10 in other studies various 
oblique planes with numerous landmarks are proposed.8, 37 One of the 
strengths of our study is the use of standardised axial planes recommended in 
routine clinical practice for biometry assessment (Table 1), and reconstruction 
from volumes allowed optimal plane finding. The approach of using 
standardised planes improve reproducibility36, 39 leading, in our case, to a high 
percentage of structures measured (90% on average) with high reproducibility 
(95% limits of agreement were within <0.3mm or <6%) (Table 3). Studies 
involving experts in neurosonography report similar results in structures 
visualisation from volume analysis.40 
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We searched for previous studies aimed to create fetal brain structures charts 
and we identified substantial heterogeneity in the methodology used.9-16, 34, 41-
67 There is high risk of bias in several domains including the selection of the 
population, the ultrasound protocol and the analysis of the data. Less than 
10% of the identified studies reported on maternal and fetal inclusion criteria, 
pregnancy outcome, ultrasound quality control and statistical method 
description. Most importantly, no studies reported on long term infant 
outcome, most probably due to the retrospective descriptive design and the 
method of collection of the data which was non-specific for the purpose of the 
study. Not surprisingly, these are common findings in creating fetal biometry 
charts as found in previous systematic reviews.18, 19 We identified only three 
studies reporting charts on the SF9, 10, 13 and only two on the POF.9, 10 
Increasing variability with advancing gestation is evident from the plotted 
values of the above studies but this was not computed in the analysis. 
Reassuringly, our observed measurements range did not differ  substantially 
from previous studies with the lowest risk of methodological bias for each of 
the six structure.10, 13-15, 41, 42 Despite all brain structures increase in size with 
advancing gestation, currently used cut-offs for normality can still be 
considered safe. For example <1% of PV and CM measurements were above 
10mm in our study.   
 
Limitations and strengths 
There are some limitations to our study. It can be argued that the use of a 
large number of sonographers obtaining data might have an impact on the 
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results; however, we felt that this more accurately reflects clinical practice.68 
In addition, the quality of the images obtained in the study was of a high 
standard and in accordance to a predefined protocol.27 The setting of near-
optimal conditions for scanning was done to minimise potential contribution of 
confounding factors and this could also be seen as a strength. It is possible 
that measurements acquired on planes extracted from three-dimensional 
volumes do not represent of fetal two-dimensional measurements. Although 
volumetry is associated with high degree or variability if not standardized,38 
once rigorous methodology is adopted, two-dimensional measurements from 
reconstructed planes can be at least as reproducible as real time 
measurements and concord to them.11, 30 
The main strength of our study is the prescriptive design, rather than the 
descriptive (how structures should grow rather than how they have grown at a 
specific point in time) which aimed to avoid limitations in previous studies 
reporting on reference charts. It was truly prospective where women were 
healthy, well nourished, educated, and at low risk of pregnancy complications. 
The strategy for population selection was population-based that initially 
selected geographical regions where women were at low risk of fetal growth 
restriction, from which, in a second step, pregnant women for FGLS were 
identified. The ultrasound measurements were taken specifically for the 
purpose of constructing international standards using a rigorous method 
implemented across all study sites; standardisation was performed using 
centrally trained staff; each study site and the coordinating unit used the same 
specially adapted ultrasound equipment to allow blinding of measurements; 
we developed a novel quality control strategy for all ultrasound 
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measurements, including assessment of intraobserver and interobserver 
variability at all sites and continual independent image review and scoring at 
the coordinating unit. Finally, the appropriate statistical methods were used to 
analyse the dataset.  
The inevitable and recurrent question related to the implementation of 
international, prescriptive growth standards is whether or not they can be 
generalised to all populations. Some authors report on differences in fetal 
brain structures size across populations. However, these studies are difficult 
to compare as populations have different demographics between each other, 
women included have high risk of fetal growth abnormality and outcome is 
scarcely reported.44, 49, 57, 63, 69 The generalisability of anthropometric 
standards based on a prescriptive approach and international sampling 
frames of geographically and ethnically diverse populations is supported by 
the uncertainty surrounding the identification of functionally significant, 
common genetic variants that are unique to ethnic groups in quantitative, 
complex traits. This is confirmed in neonatal studies analysing fetal brain 
size.70  
Our aim was to create international standards, using recommended methods 
for the analysis and the creation of charts,71, 72 that can be used in clinical 
practice. However, we did not propose to produce criteria and cut-offs for 
detection of abnormality.  
 
Conclusion 
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International standards for six fetal brain structures growth are reported. 
Objective and quantitative measurements can help to improve the screening 
and diagnostic performance of prenatal ultrasound.73, 74  
The above should represent the standards for protocols of ultrasound 
measurements and allow comparison between studies on fetal brain 
structures size and development.  
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Table 1:  Quality criteria for acquisition of the three planes. 
 
TRANSTHALAMIC  
PLANE 
TRANSVENTRICULAR 
PLANE 
TRANSCEREBELLAR 
PLANE 
Symmetrical 
hemispheres 
 
Symmetrical 
hemispheres 
Symmetrical 
hemispheres 
Cavum of the 
septum pellucidum 
present 
 
Cavum of the septum 
pellucidum present 
Cavum of the septum 
pellucidum present 
Thalami visible 
Lateral ventricles 
visible 
Thalami visible 
No cerebellum 
visible 
No cerebellum visible 
Cerebellum present at 
the maximum 
diameter 
Magnification of 30% 
image 
Magnification of 30% 
image 
Magnification of 30% 
image 
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Table 2:  Demographic details of the two populations of women recruited in 
the Fetal Brain Charts Study and the FGLS.  
 
Characteristics 
Fetal Brain Charts 
Study 
FGLS 
 N= 442 N = 4321 
Maternal age, years 28.2 (3.9) 28.4 (3.9) 
BMI, kg/m2 23.4 (3.0) 23.3 (3.0) 
Nulliparous (%) 283 (64%) 2955 (68%) 
Gestational age at first visit, weeks 11.8 (1.3) 11.8 (1.4) 
Years of formal education, years 14.0 (2.9) 15.0 (2.8) 
Preterm (<37 weeks) 22 (4.9%) 195 (5%) 
Term LBW (<2500 g; ≥37 weeks) 10 (2.2%) 128 (3%) 
Birthweight (≥37 weeks), kg 3.2 (0.4) 3.3 (0.4) 
Birth length (≥37 weeks), cm 49.2 (1.9) 49.4 (1.9) 
Birth head circumference (≥37 weeks), cm 33.9 (1.3) 33.9 (1.3) 
Pre-eclampsia 4 (<1%) 31 (<1%) 
PPROM (<37 weeks) 6 (1.3%) 80 (2%) 
Caesarean section 
 
171 (38%) 1541 (36%) 
NICU admission >1 day 
 
33 (7.4%) 240 (6%) 
Neonatal mortality 1 (<1%) 7 (<1%) 
Mother admitted to intensive care unit 1 (<1%) 17 (<1%) 
 
Maternal baseline characteristics were measured at less than 14 weeks of 
gestation. Data are mean (SD) or number (%). FGLS = fetal growth 
longitudinal study. BMI = Body Mass Index. LBW=low birthweight. 
PPROM=preterm prelabour rupture of membranes. NICU=neonatal intensive 
care unit.  
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Table 3: Equations for the estimation of the mean and SD (in mm) of each 
fetal brain structure measurement according to exact gestational age (in 
weeks)  
Parieto-occipital fissure 
Mean 10.29428 + (-12.28447*(GA/10)^-1) + ( 0.0103835*(GA/10)^3) 
SD 1.596042 + (-2.572297*(GA/10)^-2) 
Sylvian fissure 
Mean 80.27012 + (-83.29849*(GA/10)^-0.5) + (-31.67315*((GA/10)^-0.5*LN(GA/10))) 
SD 2.304501 + ( -3.53814*(GA/10)^-2) 
Anterior ventricle 
Mean 6.396214 + (0.0620535*(GA/10)^3) 
SD 1.204454 
Posterior ventricle 
Mean 4.389214 + (3.810015*(GA/10)^-1) + (0.0020063*(GA/10)^3) 
SD 0.6707227 + (0.034258*(GA)) 
Transcerebellar diameter 
Mean 6.856038+(2.913928*(GA/10)^3)+(-1.66686*(GA/10)^3*LN(GA/10)) 
SD 0.21404 + (0.1119059*(GA/10)^3) 
Cisterna Magna 
Mean EXP(2.098095 + (-2.390659*(GA/10)^-2) + (-0.0001547*(GA/10)^3)) 
SD 0.2297936 + (0.081872*(GA/10)^-2)) 
LN: natural logarithm, GA=exact gestational age. 
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Table 4: Reproducibility study 
 
 Intraobserver 
Reproducibility 
Mean 
 (95% LOA) 
Interobserver 
Reproducibility 
Mean 
 (95% LOA) 
Caliper 
replacement 
Reproducibility 
Mean 
 (95% LOA) 
Parieto-occipital fissure (mm) -0.02 (1.6) 0 (0.19) -0.01 (0.19) 
Sylvian fissure (mm) -0.01 (2.1) 0 (0.22) 0 (0.28) 
Anterior ventricle (mm) -0.01 (0.18) -0.02 (0.2) 0 (0.1) 
Posterior ventricle (mm) 0 (0.11) 0 (0.18) 0.01 (1.7) 
Transcerebellar diameter (%) -0.08 (8.6) -0.47 (11.9) -0.32 (10.54) 
Cisterna magna (mm) 0 (1.6) -0.02 (0.19) 0.01 (1.85) 
 
 
M: mean, LOA; limits of agreement; Ultrasound: ultrasound machine Philips 
HD9 using multiplanar 3D measurement modality. 
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Supplementary Table 1A: Smoothed centiles for parieto-occipital fissure (in 
mm) according to exact gestational age (in weeks).  
GA Sample C5 C50 C95 
15 18 1.39 2.14 2.88 
16 18 1.69 2.66 3.63 
17 18 1.96 3.12 4.28 
18 19 2.21 3.53 4.85 
19 19 2.45 3.90 5.35 
20 21 2.67 4.24 5.80 
21 16 2.87 4.54 6.21 
22 18 3.07 4.82 6.57 
23 21 3.25 5.08 6.90 
24 18 3.43 5.32 7.21 
25 20 3.59 5.54 7.49 
26 19 3.75 5.75 7.75 
27 19 3.90 5.95 7.99 
28 19 4.05 6.13 8.22 
29 22 4.19 6.31 8.43 
30 21 4.32 6.48 8.63 
31 20 4.46 6.64 8.83 
32 17 4.58 6.80 9.01 
33 22 4.71 6.94 9.18 
34 21 4.83 7.09 9.35 
35 19 4.95 7.23 9.51 
36 15 5.07 7.37 9.67 
Total 
Measurements 420       
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Supplementary Table 1B: Smoothed centiles for sylvian fissure (in mm) 
according to exact gestational age (in weeks).  
GA Sample C5 C50 C95 
15 18 0.57 1.77 2.98 
16 15 1.13 2.65 4.17 
17 18 1.72 3.49 5.27 
18 18 2.31 4.31 6.30 
19 17 2.91 5.09 7.27 
20 20 3.51 5.85 8.18 
21 15 4.10 6.57 9.04 
22 18 4.69 7.27 9.86 
23 20 5.26 7.95 10.64 
24 17 5.82 8.60 11.38 
25 20 6.37 9.23 12.09 
26 18 6.91 9.84 12.77 
27 16 7.44 10.43 13.42 
28 19 7.95 11.00 14.05 
29 22 8.45 11.55 14.65 
30 20 8.94 12.09 15.23 
31 20 9.42 12.61 15.79 
32 17 9.89 13.11 16.33 
33 22 10.34 13.60 16.86 
34 22 10.79 14.07 17.36 
35 18 11.22 14.54 17.85 
36 14 11.64 14.99 18.33 
Total 
Measurements 404       
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Supplementary Table 1C: Smoothed centiles for anterior ventricle (in mm) 
according to exact gestational age (in weeks). 
GA Sample C5 C50 C95 
15 17 4.62 6.61 8.59 
16 15 4.67 6.65 8.63 
17 17 4.72 6.70 8.68 
18 18 4.78 6.76 8.74 
19 19 4.84 6.82 8.80 
20 20 4.91 6.89 8.87 
21 15 4.99 6.97 8.95 
22 18 5.08 7.06 9.04 
23 21 5.17 7.15 9.13 
24 15 5.27 7.25 9.24 
25 19 5.38 7.37 9.35 
26 18 5.51 7.49 9.47 
27 17 5.64 7.62 9.60 
28 19 5.78 7.76 9.74 
29 22 5.93 7.91 9.89 
30 19 6.09 8.07 10.05 
31 17 6.26 8.24 10.23 
32 13 6.45 8.43 10.41 
33 18 6.65 8.63 10.61 
34 17 6.85 8.84 10.82 
35 15 7.08 9.06 11.04 
36 9 7.31 9.29 11.27 
Total 
Measurements 378       
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Supplementary Table 1D: Smoothed centiles for posterior ventricle (in mm) 
according to exact gestational age (in weeks). 
GA Sample C5 C50 C95 
15 18 4.99 6.94 8.88 
16 19 4.77 6.78 8.78 
17 18 4.58 6.64 8.70 
18 19 4.40 6.52 8.64 
19 19 4.23 6.41 8.58 
20 22 4.08 6.31 8.54 
21 16 3.94 6.22 8.51 
22 18 3.80 6.14 8.49 
23 21 3.67 6.07 8.47 
24 18 3.55 6.00 8.46 
25 20 3.43 5.94 8.46 
26 19 3.32 5.89 8.46 
27 19 3.22 5.84 8.46 
28 19 3.11 5.79 8.48 
29 22 3.01 5.75 8.49 
30 21 2.92 5.71 8.51 
31 20 2.83 5.68 8.53 
32 17 2.74 5.65 8.55 
33 22 2.65 5.62 8.58 
34 22 2.57 5.59 8.61 
35 19 2.49 5.56 8.64 
36 14 2.41 5.54 8.67 
Total 
Measurements 422       
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Supplementary Table 1E: Smoothed centiles for transcerebellar diameter (in 
mm) according to exact gestational age (in weeks). 
GA Sample C5 C50 C95 
15 19 13.44 14.41 15.38 
16 18 14.48 15.58 16.69 
17 18 15.57 16.83 18.08 
18 19 16.71 18.14 19.56 
19 19 17.89 19.50 21.12 
20 21 19.10 20.92 22.75 
21 16 20.33 22.39 24.45 
22 18 21.58 23.89 26.20 
23 21 22.83 25.42 28.01 
24 18 24.07 26.97 29.86 
25 17 25.29 28.52 31.75 
26 19 26.49 30.08 33.67 
27 17 27.65 31.62 35.60 
28 18 28.76 33.15 37.54 
29 21 29.80 34.64 39.48 
30 18 30.77 36.09 41.41 
31 17 31.65 37.48 43.32 
32 16 32.43 38.81 45.19 
33 19 33.09 40.06 47.02 
34 17 33.62 41.21 48.80 
35 14 34.02 42.26 50.50 
36 10 34.25 43.19 52.13 
Total 
Measurements 390       
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Supplementary Table 1F: Smoothed centiles for cisterna magna (in mm) 
according to exact gestational age (in weeks). 
GA Sample C5 C50 C95 
15 19 1.82 2.82 4.36 
16 17 2.08 3.20 4.92 
17 17 2.33 3.56 5.44 
18 18 2.56 3.89 5.92 
19 19 2.77 4.20 6.36 
20 21 2.97 4.48 6.76 
21 15 3.15 4.73 7.12 
22 18 3.31 4.97 7.45 
23 21 3.46 5.18 7.75 
24 16 3.60 5.37 8.02 
25 17 3.72 5.55 8.27 
26 19 3.83 5.71 8.50 
27 15 3.94 5.85 8.70 
28 16 4.03 5.99 8.89 
29 20 4.12 6.11 9.06 
30 16 4.20 6.22 9.22 
31 13 4.27 6.33 9.36 
32 14 4.34 6.42 9.49 
33 12 4.40 6.51 9.62 
34 13 4.46 6.59 9.73 
35 11 4.51 6.66 9.83 
36 5 4.56 6.73 9.92 
Total 
Measurements 352       
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Figure 1: Planes reconstructed and caliper placement for brain structures acquisition at different weeks of gestation. W: completed weeks of 
gestation, TT: transthalamic plane, TV: transventricular plane, TC: transcerebellar plane, POF: parieto-occipital fissure, SF: sylvian fissure, 
AV: anterior ventricle, PV: posterior ventricle, TCD: transcerebellar diameter, CM: cisterna magna. 
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Figure 2: Fetal brain charts study flow chart 
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Figure 3A: Fitted 5th, 50th, and 95th smoothed centile curves of parieto-
occipital fissure. 
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Figure 3B: Fitted 5th, 50th, and 95th smoothed centile curves of sylvian fissure. 
 
 
   
 
179 
Figure 3C: Fitted 5th, 50th, and 95th smoothed centile curves of anterior 
ventricle. 
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Figure 3D: Fitted 5th, 50th, and 95th smoothed centile curves of posterior 
ventricle. 
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Figure 3E: Fitted 5th, 50th, and 95th smoothed centile curves of transcerebellar 
diameter. 
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Figure 3F: Fitted 5th, 50th, and 95th smoothed centile curves of cisterna 
magna. 
 
 
 
Supplementary Figure 1A: Bland–Altman plots showing intraobserver 
reproducibility for volume manipulation and caliper placement for 
measurement acquisition. 
 
 
  
  
 
Parieto-occipital fissure Sylvian fissure 
 
 
 
+1.96 SD = 0.14 
-1.96 SD = -0.17 
+1.96 SD = 0.20 
-1.96 SD = -0.22 
Mean = -0.02 
Mean = -0.01 
+1.96 SD = 0.12 
-1.96 SD = -0.11 
Mean = -0.00 
+1.96 SD = 8.57 
-1.96 SD = -8.73 
Mean = -0.08 
+1.96 SD = 0.16 
-1.96 SD = -0.17 
Mean = -0.00 
 
+1.96 SD = 0.17 
-1.96 SD = -0.19 
Mean = -0.01 
Anterior ventricle Posterior ventricle 
Transcerebellar diameter Cisterna magna 
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Supplementary Figure 1B: Bland–Altman plots showing interobserver 
reproducibility for volume manipulation and caliper placement for 
measurement acquisition. 
 
 
 
 
  
  
  
+1.96 SD = 0.19 
-1.96 SD = -0.20 
Mean = -0.00 
+1.96 SD = 0.23 
-1.96 SD = -0.22 
Mean = 0.00 
+1.96 SD = 0.19 
-1.96 SD = -0.22 
Mean = -0.02 
+1.96 SD = 0.19 
-1.96 SD = -0.18 
Mean = 0.00 
+1.96 SD = 11.43 
-1.96 SD = -12.37 
Mean = -0.47 
+1.96 SD = 0.18 
-1.96 SD = -0.21 
Mean = -0.02 
Parieto-occipital fissure Sylvian fissure 
 
Anterior ventricle Posterior ventricle 
Transcerebellar diameter Cisterna magna 
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Supplementary Figure 1C: Bland–Altman plots showing interobserver reproducibility for 
caliper replacement on stored planes. 
 
 
 
 
 
  
 
 
 
 
+1.96 SD = 0.29 
-1.96 SD = -0.28 
Mean = 0.00 
+1.96 SD = 0.19 
-1.96 SD = -0.20 
Mean = -0.01 
+1.96 SD = 0.18 
-1.96 SD = -0.19 
Mean = -0.00 
+1.96 SD = 0.18 
-1.96 SD = -0.17 
Mean = -0.01 
+1.96 SD = 10.23 
-1.96 SD = -10.86 
Mean = -0.32 
+1.96 SD = 0.19 
-1.96 SD = -0.18 
Mean = 0.01 
Parieto-occipital fissure Sylvian fissure 
 
Anterior ventricle Posterior ventricle 
Transcerebellar diameter Cisterna magna 
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CONCLUSION 
 
 
The main aim of this project was to create international standards for fetal 
brain structures size using ultrasound measurements. 
Fetal brain growth and development is routinely studied using prenatal 
ultrasound. Ultrasound is used mainly in antenatal care to diagnose fetal 
abnormalities6-14 but it is also essential in evaluating fetal growth and 
central nervous system development. It has been demonstrated how FGR 
can affect neurodevelopment and therefore a population at low risk of 
FGR should be selected to create such standards (Appendix 1).31, 32  
Women recruited in the FGLS of the INTERGROWTH-21st Project 
represent the ideal candidate. This study uses a ‘prescriptive’ other than a 
‘descriptive’ design to study the fetal growth, i.e. only children from 
populations with minimal environmental constraints on growth were 
included. Previous studies on fetal growth are associated with high risk of 
bias when a descriptive approach was used (Appendix 2). The population 
recruited in the fetal structures brain study was representative of the FGLS 
in view of low incidence of adverse pregnancy outcome and normal motor 
development. 
Ultrasound technology requires the input of several software analysis 
functions to increase the diagnostic performance, the clinical use and 
assist in the measurements evaluation when creating standards. A second 
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line of research associated with this aim has been reported in this 
manuscript showing promising results of automatic software analysis in 
terms of accuracy (80-90%) and reproducibility when compared with 
experts (Appendix 3, 4, 5).  
One of the source of high variability between different charts reporting of 
fetal growth is the absence of a comprehensive quality control strategy in 
fetal ultrasound.36-38 The above has been a novel component of the FGLS 
study39-42 and several strategies to implement quality control have been 
studied and demonstrated to be highly reproducible (Appendix 6, 7, 8). 
 
A systematic review of the literature has been performed to identify all the 
studies aimed to create brain structures charts. There is substantial 
heterogeneity in the methodology used in previous studies aimed to create 
brain structures charts.43-52 and high risk of bias in several domains. Most 
importantly, no studies reported on long term infant outcome. As a 
conclusion international standards are required.  
 
To conclude, international standards for six fetal brain structures size 
measured by antenatal ultrasound have been created with the highest 
quality methodology and good results of the model fitted. Those standards 
provide guidelines for ultrasound evaluation of the fetal brain and further 
understanding into the fetal brain development process in babies at low 
risk of abnormal neurological outcome (Appendix 9).  
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